Document:

EX-10.10

 Exhibit 10.10 

EMPLOYMENT AGREEMENT 

This Employment Agreement (“Agreement”) is made between Fusion Pharmaceuticals Inc. (“Parent Company”), Fusion
Pharmaceuticals US, Inc., a Delaware corporation and US subsidiary of the Parent Company (the “Company”), and James O’Leary (the “Executive”) and is effective as of the closing of the first underwritten public offering of
the equity securities of the Parent Company pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Effective Date”). Except with respect to the Restrictive Covenants Agreement and the Equity
Documents (each as defined below), this Agreement supersedes in all respects all prior agreements between the Executive and the Parent Company and/or the Company regarding the subject matter herein, including without limitation (i) the
Employment Agreement between the Executive and the Parent Company dated March 11, 2020 (the “Prior Agreement”), provided that the Executive’s repayment obligation with respect to the Signing Bonus in Section 6 of the Prior
Agreement shall remain in effect until March 16, 2021, and (ii) any offer letter, employment agreement or severance agreement. 

WHEREAS, the Company desires to continue to employ the Executive and the Executive desires to continue to be employed by the Company on the
new terms and conditions contained herein. 
 NOW, THEREFORE, in consideration of the mutual covenants and agreements herein
contained and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows: 

1.    Employment. 

(a)    Term. The Company shall employ the Executive and the Executive shall be employed by the Company pursuant to
this Agreement commencing as of the Effective Date and continuing until such employment is terminated in accordance with the provisions hereof (the “Term”). The Executive’s employment with the Company will continue to be “at
will,” meaning that the Executive’s employment may be terminated by the Company or the Executive at any time and for any reason subject to the terms of this Agreement. 

(b)    Position and Duties. The Executive shall serve as the Chief Medical Officer of the Parent Company and shall
have such powers and duties commensurate with the position of Chief Medical Officer and as may from time to time be prescribed by the Chief Executive Officer (the “CEO”) or the “CEO’s Designate” (as defined below). At all
times during the Term, the Executive shall report to the CEO or the CEO’s Designate. For purposes of this Agreement, “CEO’s Designate” shall mean such other person discharging the duties of the CEO. The Executive shall devote the
Executive’s full working time and efforts to the business and affairs of the Company. Notwithstanding the foregoing, the Executive may serve on other boards of directors, with the approval of the Board of Directors of the Parent Company
(the “Board”), or engage in religious, charitable or other community activities as long as such services and activities are disclosed to the Board and do not interfere with the Executive’s performance of the Executive’s
duties to the Company. 

 2.    Compensation and Related Matters. 

(a)    Base Salary. The Executive’s initial base salary shall be paid at the rate of $438,300 per year. The
Executive’s base salary shall be subject to periodic review by the Board or the Compensation Committee of the Board (the “Compensation Committee”). The base salary in effect at any given time is referred to herein as “Base
Salary.” The Base Salary shall be payable in a manner that is consistent with the Company’s usual payroll practices for executive officers. 

(b)    Incentive Compensation. The Executive shall be eligible to receive an annual discretionary bonus of up to
forty percent (40%) of the Executive’s Base Salary (the “Target Bonus”) as determined by the Board or the Compensation Committee from time to time. The actual amount of the Executive’s annual incentive compensation, if any, shall
be determined in the sole discretion of the Board or the Compensation Committee. Any bonus pursuant to this Section that the Executive may receive may vary significantly from year to year. There is no representation that a bonus in one year will be
comparable to another year. There is no implied term that, if the amount of any bonus is lower in any subsequent year, the Company will compensate the Executive for such difference. Under no circumstances is the bonus to be considered part of the
Base Salary or other regular employment income. The bonus, if any, will be paid when the Company normally pays such bonuses and is not earned or accrued until the bonus payout date. Except as otherwise provided herein, to earn incentive
compensation, the Executive must be employed by the Company on the day such incentive compensation is paid. 

(c)    Expenses. The Executive shall be entitled to receive prompt reimbursement for all reasonable expenses
incurred by the Executive during the Term in performing services hereunder, in accordance with the policies and procedures then in effect and established by the Company for its executive officers. 

(d)    Other Benefits. The Executive shall be eligible to participate in or receive benefits under the
Company’s employee benefit plans in effect from time to time, subject to the terms of such plans. 

(e)    Vacation. Subject to the terms and conditions of the Company’s vacation policy in effect from time to
time, the Executive will be eligible to accrue up to four (4) weeks of paid vacation in each calendar year, accrued pro-rata on a monthly basis, to be taken at times agreed upon by the Executive and the
Company. Vacation time must accrue before the Executive may use it, except upon written approval of the Company, which approval will be at the sole discretion of the Company. The Company reserves the right to require the Executive to take some or
all of the accrued vacation days at any time during scheduled or unscheduled office shut-down periods, at its sole discretion. Forfeiture of unused vacation days will be subject to the Company’s vacation policy as in effect from time to time.

 (f)    Retention Bonus. The Executive shall be provided with a
one-time retention bonus in the amount of $1,000 as consideration for entering into the Restrictive Covenants Agreement (as defined below). 

 (g)    Equity. The equity awards held by the Executive shall
continue to be governed by the terms and conditions of the Parent Company’s applicable equity incentive plan(s) and the applicable award agreement(s) governing the terms of such equity awards held by the Executive (collectively, the
“Equity Documents”); provided, however, and notwithstanding anything to the contrary in the Equity Documents, Section 6(a)(ii) of this Agreement shall apply in the event of a termination by the Company without Cause or by the
Executive for Good Reason in either event within the Change in Control Period (as such terms are defined below). 

(h)    Indemnification. During and after the Term, the Executive shall be entitled to indemnification pursuant to
the Parent Company’s and Company’s articles of organization and/or by-laws, as applicable, and applicable state law. 

3.    Termination. In the event Executive’s employment is terminated, the Executive shall be deemed to have
resigned from all officer and board member positions that the Executive holds with the Parent Company or any of its respective subsidiaries and affiliates upon the termination of the Executive’s employment for any reason. The Executive shall
execute any documents in reasonable form as may be requested to confirm or effectuate any such resignations. The Executive’s employment hereunder may be terminated without any breach of this Agreement under the following circumstances: 

(a)    Death. The Executive’s employment hereunder shall terminate upon death. 

(b)    Disability. The Company may terminate the Executive’s employment if the Executive is disabled and
unable to perform or expected to be unable to perform the essential functions of the Executive’s then existing position or positions under this Agreement with or without reasonable accommodation for a period of 180 days (which need not be
consecutive) in any 12-month period. If any question shall arise as to whether during any period the Executive is disabled so as to be unable to perform the essential functions of the Executive’s then
existing position or positions with or without reasonable accommodation, the Executive may, and at the request of the Company shall, submit to the Company a certification in reasonable detail by a board-certified physician selected by the Company to
whom the Executive or the Executive’s guardian has no reasonable objection as to whether the Executive is so disabled or how long such disability is expected to continue, and such certification shall for the purposes of this Agreement be
conclusive of the issue. The Executive shall cooperate with any reasonable request of the physician in connection with such certification. If such question shall arise and the Executive shall fail to submit such certification, the Company’s
determination of such issue shall be binding on the Executive. Nothing in this Section 3(b) shall be construed to waive the Executive’s rights, if any, under existing law including, without limitation, the Family and Medical Leave Act of
1993, 29 U.S.C. §2601 et seq. and the Americans with Disabilities Act, 42 U.S.C. §12101 et seq. 

 (c)    Termination by Company for Cause. The Company may
terminate the Executive’s employment hereunder for Cause. For purposes of this Agreement, “Cause” shall mean any of the following: 

(i)    conduct by the Executive constituting a material act of misconduct in connection with the performance of the
Executive’s duties that would reasonably be expected to result in injury or reputational harm to the Company or any of its subsidiaries or affiliates if the Executive were to continue to be employed in the same position, including, without
limitation, (A) willful failure or refusal to perform material responsibilities that have been requested by the CEO; (B) dishonesty with respect to any material matter; or (C) misappropriation of funds or property of the
Company or any of its subsidiaries or affiliates other than the occasional, customary and de minimis use of Company property for personal purposes; 

(ii)    the commission by the Executive of acts satisfying the elements of (A) any felony or (B) a misdemeanor
involving moral turpitude, deceit, dishonesty or fraud; 
 (iii)    any misconduct by the Executive, regardless of
whether or not in the course of the Executive’s employment, that would reasonably be expected to result in material injury or reputational harm to the Company or any of its subsidiaries or affiliates if the Executive were to continue to be
employed in the same position; 
 (iv)    a breach by the Executive of any of the material provisions contained in
Section 8 of this Agreement or the Restrictive Covenants Agreement (as defined below); 
 (v)    a material
violation by the Executive of any of the Company’s written policies that would reasonably be expected to result in material injury or reputational harm to the Company or any of its subsidiaries or affiliates if the Executive were to continue to
be employed in the same position; or 
 (vi)    the Executive’s failure to cooperate with a bona fide internal
investigation or an investigation by regulatory or law enforcement authorities, after being instructed by the Parent Company or Company to cooperate, or the willful destruction or failure to preserve documents or other materials known to be relevant
to such investigation or the inducement of others to fail to cooperate or to produce documents or other materials in connection with such investigation. 

Notwithstanding anything to the contrary in the foregoing, any purported termination for Cause under subsections (i), (iii), (iv), (v) or (vi) above
shall not be effective unless and until (A) the Company has provided Executive with Notice of Termination that describes in reasonable detail the facts and circumstances giving rise to the termination for Cause and (B) to the extent the
Executive’s action (or inaction) is curable as reasonably determined in the Company’s discretion, the Executive has been afforded an opportunity of not less than fourteen (14) days in which to cure the
complained-of action (or inaction) described in the Notice of Termination. 

(d)    Termination by the Company without Cause. The Company may terminate the Executive’s employment
hereunder at any time without Cause. Any termination by the Company of the Executive’s employment under this Agreement which does not constitute a termination for Cause under Section 3(c) and does not result from the death or disability of
the Executive under Section 3(a) or (b) shall be deemed a termination without Cause. 

 (e)    Termination by the Executive. The Executive may terminate
employment hereunder at any time for any reason, including but not limited to, Good Reason. For purposes of this Agreement, “Good Reason” shall mean that the Executive has completed all steps of the Good Reason Process (hereinafter
defined) following the occurrence of any of the following events without the Executive’s consent (each, a “Good Reason Condition”): 

(i)    an adverse change in the Executive’s position or a material diminution in the Executive’s
responsibilities, authority or duties; 
 (ii)    a reduction of twenty percent (20%) or more to the
Executive’s Base Salary or Target Bonus except for across-the-board salary or compensation reductions based on the Company’s financial performance similarly
affecting all or substantially all senior management employees of the Company; 
 (iii)    a material
change in the geographic location at which the Executive provides services to the Company, such that there is an increase of at least thirty (30) miles of driving distance to such location from the Executive’s principal residence as of
such change; 
 (iv)    a material breach of this Agreement by the Company; or 

(v)    the failure of any successor to the Company or Parent Company to fully assume this Agreement. 

The “Good Reason Process” consists of the following steps: 

(i)    the Executive reasonably determines in good faith that a Good Reason Condition has occurred; 

(ii)    the Executive notifies the Company in writing of the first occurrence of the Good Reason Condition
within ninety (90) days of the first occurrence of such condition; 
 (iii)    the Executive
cooperates in good faith with the Company’s efforts, for a period of 30 days following such notice (the “Cure Period”), to remedy the Good Reason Condition; 

(iv)    notwithstanding such efforts, the Good Reason Condition continues to exist; and 

(v)    the Executive terminates employment within thirty (30) days after the end of the Cure Period.

 If the Company cures the Good Reason Condition during the Cure Period, Good Reason shall be deemed not to have occurred. 

If the Executive’s employment with the Company is terminated for any reason, the Company shall pay or provide to the Executive (or to the
Executive’s authorized representative or estate) 

 
(i) any Base Salary earned through the Date of Termination; (ii) unpaid expense reimbursements (subject to, and in accordance with, Section 2(c) of this Agreement); (iii) accrued but
unused vacation pay through the Date of Termination; and (iv) any vested benefits the Executive may have under any employee benefit plan of the Company through the Date of Termination, which vested benefits shall be paid and/or provided in
accordance with the terms of such employee benefit plans (collectively, the “Accrued Obligations”). 

4.    Notice and Date of Termination. 

(a)    Notice of Termination. Except for termination as specified in Section 3(a), any termination of the
Executive’s employment by the Company or any such termination by the Executive shall be communicated by written Notice of Termination to the other party hereto. For purposes of this Agreement, a “Notice of Termination” shall mean a
notice which shall indicate the specific termination provision (by subsection) in this Agreement relied upon. 

(b)    Date of Termination. “Date of Termination” shall mean: (i) if the Executive’s employment
is terminated by death, the date of death; (ii) if the Executive’s employment is terminated on account of disability under Section 3(b), the date on which Notice of Termination is given; (iii) if the Executive’s employment
is terminated by the Company for Cause under Section 3(c), and the Company determines that the Executive’s action or inaction is curable, the date which is fourteen (14) days after the date on which the Notice of Termination is given,
and if the Company determines that the Executive’s action or inaction is not curable, or if a cure period is not required under Section 3(c), the date on which the Notice of Termination is given; (iv) if the Executive’s
employment is terminated by the Company without Cause under Section 3(d), the date on which a Notice of Termination is given or the date otherwise specified by the Company in the Notice of Termination; (v) if the Executive’s
employment is terminated by the Executive under Section 3(e) other than for Good Reason, thirty (30) days after the date on which a Notice of Termination is given, and (vi) if the Executive’s employment is terminated by the
Executive under Section 3(e) for Good Reason, the date on which a Notice of Termination is given after the end of the Cure Period. Notwithstanding the foregoing, in the event that the Executive gives a Notice of Termination to the Company, the
Company may unilaterally accelerate the Date of Termination and such acceleration shall not result in a termination by the Company for purposes of this Agreement. 

5.    Severance Pay and Benefits Upon Termination by the Company without Cause or by the Executive for Good Reason
Outside the Change in Control Period. If the Executive’s employment is terminated by the Company without Cause as provided in Section 3(d), or the Executive terminates employment for Good Reason as provided in Section 3(e), each
outside of the Change in Control Period (as defined below), then, in addition to the Accrued Obligations, and subject to (i) the Executive signing a separation agreement and release in a form and manner satisfactory to the Company, which
shall include, without limitation, a general release of claims against the Company and all related persons and entities, a reaffirmation of all of the Executive’s Continuing Obligations (as defined below), and, in the Company’s sole
discretion, a one-year post-employment noncompetition agreement substantially similar to or the same as the noncompetition provision in Section 8(c) of the Restrictive Covenant Agreement, and shall
provide that if the Executive breaches any of the Continuing Obligations, all payments of the Severance Amount shall immediately cease (the “Separation Agreement and Release”), and (ii) 

 
the Separation Agreement and Release becoming irrevocable, all within 60 days after the Date of Termination (or such shorter period as set forth in the Separation Agreement and Release), which
shall include a seven (7) business day revocation period: 
 (a)    the Company shall pay the Executive an amount
equal to twelve (12) months of the Executive’s Base Salary (the “Severance Amount”); provided in the event the Executive is entitled to any payments pursuant to the Restrictive Covenants Agreement, the Severance Amount
received in any calendar year will be reduced by the amount the Executive is paid in the same such calendar year pursuant to the Restrictive Covenants Agreement (the “Restrictive Covenants Agreement Setoff”); and 

(b)    subject to the Executive’s copayment of premium amounts at the applicable active employees’ rate and the
Executive’s proper election to receive benefits under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”), the Company shall pay to the group health plan provider, the COBRA provider or the
Executive a monthly payment equal to the monthly employer contribution that the Company would have made to provide health insurance to the Executive if the Executive had remained employed by the Company until the earliest of (A) the 12-month anniversary of the Date of Termination; (B) the Executive’s eligibility for group medical plan benefits under any other employer’s group medical plan; or (C) the cessation of the
Executive’s continuation rights under COBRA; provided, however, if the Company determines that it cannot pay such amounts to the group health plan provider or the COBRA provider (if applicable) without potentially violating applicable law
(including, without limitation, Section 2716 of the Public Health Service Act), then the Company shall convert such payments to payroll payments directly to the Executive for the time period specified above. Such payments shall be subject to tax-related deductions and withholdings and paid on the Company’s regular payroll dates; and 

(c)    the Company shall pay the Executive an amount equal to (i) any incentive compensation pursuant to
Section 2(b) of this Agreement awarded in respect of the year preceding the year of termination but not yet paid (the “Prior Year’s Bonus”), and (ii) a pro-rated Target Bonus up to the
Date of Termination. 
 The amounts payable under Section 5, to the extent taxable, shall be paid out in substantially equal installments in accordance
with the Company’s payroll practice over twelve (12) months commencing within 60 days after the Date of Termination; provided, however, that if the 60-day period begins in one calendar year
and ends in a second calendar year, the Severance Amount, to the extent it qualifies as “non-qualified deferred compensation” within the meaning of Section 409A of the Internal Revenue Code of
1986, as amended (the “Code”), shall begin to be paid in the second calendar year by the last day of such 60-day period; provided, further, that the initial payment shall include a catch-up payment to cover amounts retroactive to the day immediately following the Date of Termination. Each payment pursuant to this Agreement is intended to constitute a separate payment for purposes of Treasury
Regulation Section 1.409A-2(b)(2). 
 6.    Severance Pay and Benefits
Upon Termination by the Company without Cause or by the Executive for Good Reason within the Change in Control Period. The provisions of this Section 6 shall apply in lieu of, and expressly supersede, the provisions of Section 5 if
(i) the Executive’s employment is terminated either (a) by the Company without Cause as provided in 

 
Section 3(d), or (b) by the Executive for Good Reason as provided in Section 3(e), and (ii) the Date of Termination is within 12 months after the occurrence of the first event
constituting a Change in Control (such period, the “Change in Control Period”). These provisions shall terminate and be of no further force or effect after a Change in Control Period. 

(a)    If the Executive’s employment is terminated by the Company without Cause as provided in Section 3(d) or
the Executive terminates employment for Good Reason as provided in Section 3(e) and in each case the Date of Termination occurs during the Change in Control Period, then, in addition to the Accrued Obligations, and subject to the signing of the
Separation Agreement and Release by the Executive and the Separation Agreement and Release becoming fully effective, all within the time frame set forth in the Separation Agreement and Release but in no event more than 60 days after the Date of
Termination: 
 (i)    the Company shall pay the Executive a lump sum in cash in an amount equal to the
Executive’s then current Base Salary (or the Executive’s Base Salary in effect immediately prior to the Change in Control, if higher) (the “Change in Control Payment”); provided the Change in Control Payment shall be reduced by
the amount of the Restrictive Covenants Agreement Setoff, if applicable; and 
 (ii)    notwithstanding
anything to the contrary in any applicable option agreement or other stock-based award agreement, all time-based stock options and other stock-based awards subject to time-based vesting held by the Executive (the “Time-Based Equity
Awards”) shall immediately accelerate and become fully exercisable or nonforfeitable as of the later of (i) the Date of Termination or (ii) the effective date of the Separation Agreement and Release (the “Accelerated Vesting
Date”); provided that any termination or forfeiture of the unvested portion of such Time-Based Equity Awards that would otherwise occur on the Date of Termination in the absence of this Agreement will be delayed until the effective date
of the Separation Agreement and Release and will only occur if the vesting pursuant to this subsection does not occur due to the absence of the Separation Agreement and Release becoming fully effective within the time period set forth therein.
Notwithstanding the foregoing, no additional vesting of the Time-Based Equity Awards shall occur during the period between the Executive’s Date of Termination and the Accelerated Vesting Date; and 

(iii)    subject to the Executive’s copayment of premium amounts at the applicable active
employees’ rate and the Executive’s proper election to receive benefits under COBRA, the Company shall pay to the group health plan provider, the COBRA provider or the Executive a monthly payment equal to the monthly employer contribution
that the Company would have made to provide health insurance to the Executive if the Executive had remained employed by the Company until the earliest of (A) the 12-month anniversary of the Date of
Termination; (B) the Executive’s eligibility for group medical plan benefits under any other employer’s group medical plan; or (C) the cessation of the Executive’s continuation rights under COBRA; provided, however, if the
Company determines that it cannot pay such amounts to the group health plan provider or the COBRA provider (if applicable) without potentially violating applicable law (including, without limitation, Section 2716 of the Public Health Service
Act), then the Company shall convert such payments to payroll payments directly to the Executive for the time period specified above. Such payments shall be subject to tax-related deductions and withholdings
and paid on the Company’s regular payroll dates; and 

 (iv)    the Company shall pay the Executive an amount
equal to (i) the Prior Year’s Bonus, and (ii) the Executive’s Target Bonus for the then-current year. 
 The amounts payable under this
Section 6(a), to the extent taxable, shall be paid or commence to be paid within 60 days after the Date of Termination; provided, however, that if the 60-day period begins in one calendar year and ends in
a second calendar year, such payments to the extent they qualify as “non-qualified deferred compensation” within the meaning of Section 409A of the Code, shall be paid or commence to be paid in
the second calendar year by the last day of such 60-day period. 

(b)    Additional Limitation. 

(i)    Anything in this Agreement to the contrary notwithstanding, in the event that the amount of any
compensation, payment or distribution by the Company to or for the benefit of the Executive, whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise, calculated in a manner consistent with
Section 280G of the Code, and the applicable regulations thereunder (the “Aggregate Payments”), would be subject to the excise tax imposed by Section 4999 of the Code, then the Aggregate Payments shall be reduced (but not below
zero) so that the sum of all of the Aggregate Payments shall be $1.00 less than the amount at which the Executive becomes subject to the excise tax imposed by Section 4999 of the Code; provided that such reduction shall only occur if it would
result in the Executive receiving a higher After Tax Amount (as defined below) than the Executive would receive if the Aggregate Payments were not subject to such reduction. In such event, the Aggregate Payments shall be reduced in the following
order, in each case, in reverse chronological order beginning with the Aggregate Payments that are to be paid the furthest in time from consummation of the transaction that is subject to Section 280G of the Code: (1) cash payments not
subject to Section 409A of the Code; (2) cash payments subject to Section 409A of the Code; (3) equity-based payments and acceleration; and (4) non-cash forms of benefits; provided
that in the case of all the foregoing Aggregate Payments all amounts or payments that are not subject to calculation under Treas. Reg. §1.280G-1, Q&A-24(b) or
(c) shall be reduced before any amounts that are subject to calculation under Treas. Reg. §1.280G-1, Q&A-24(b) or (c). 

(ii)    For purposes of this Section 6(b), the “After Tax Amount” means the amount of the
Aggregate Payments less all federal, state, and local income, excise and employment taxes imposed on the Executive as a result of the Executive’s receipt of the Aggregate Payments. For purposes of determining the After Tax Amount, the Executive
shall be deemed to pay federal income taxes at the highest marginal rate of federal income taxation applicable to individuals for the calendar year in which the determination is to be made, and state and local income taxes at the highest marginal
rates of individual taxation in each applicable state and locality, net of the maximum reduction in federal income taxes which could be obtained from deduction of such state and local taxes. 

 (iii)    The determination as to whether a reduction in
the Aggregate Payments shall be made pursuant to Section 6(b)(i) shall be made by a nationally recognized accounting firm selected by the Company (the “Accounting Firm”), which shall provide detailed supporting calculations both to
the Company and the Executive within 15 business days of the Date of Termination, if applicable, or at such earlier time as is reasonably requested by the Company or the Executive. Any determination by the Accounting Firm shall be binding upon the
Company and the Executive. The Company shall pay the Accounting Firm’s fees. 
 (c)    Definitions. For
purposes of this Section 6, the following terms shall have the following meanings: 
 “Change in Control” shall mean any of
the following: 
 (i)    any “person,” as such term is used in Sections 13(d) and 14(d) of the
Securities Exchange Act of 1934, as amended (the “Act”) (other than the Company, any of its subsidiaries, or any trustee, fiduciary or other person or entity holding securities under any employee benefit plan or trust of the Company or any
of its subsidiaries), together with all “affiliates” and “associates” (as such terms are defined in Rule 12b-2 under the Act) of such person, shall become the “beneficial owner”
(as such term is defined in Rule 13d-3 under the Act), directly or indirectly, of securities of the Company representing 50 percent or more of the combined voting power of the Company’s then
outstanding securities having the right to vote in an election of the Board (“Voting Securities”) (in such case other than as a result of an acquisition of securities directly from the Company); or 

(ii)    the date a majority of the members of the Board is replaced during any 12-month period by directors whose appointment or election is not endorsed by a majority of the members of the Board before the date of the appointment or election; or 

(iii)    the consummation of (A) any consolidation or merger of the Company where the stockholders of
the Company, immediately prior to the consolidation or merger, would not, immediately after the consolidation or merger, beneficially own (as such term is defined in Rule 13d-3 under the Act), directly or
indirectly, shares representing in the aggregate more than 50 percent of the voting shares of the Company issuing cash or securities in the consolidation or merger (or of its ultimate parent corporation, if any), or (B) any sale or other
transfer (in one transaction or a series of transactions contemplated or arranged by any party as a single plan) of all or substantially all of the assets of the Company. 

Notwithstanding the foregoing, a “Change in Control” shall not be deemed to have occurred for purposes of the foregoing clause
(i) solely as the result of an acquisition of securities by the Company which, by reducing the number of shares of Voting Securities outstanding, increases the proportionate number of Voting Securities beneficially owned by any person to
50 percent or more of the combined voting power of all of the then outstanding Voting Securities; provided, however, that if any person referred to in this sentence shall thereafter become the beneficial owner of any additional shares of Voting
Securities (other than pursuant to 

 
a stock split, stock dividend, or similar transaction or as a result of an acquisition of securities directly from the Company) and immediately thereafter beneficially owns 50 percent or
more of the combined voting power of all of the then outstanding Voting Securities, then a “Change in Control” shall be deemed to have occurred for purposes of the foregoing clause (i). 

7.    Section 409A. 

(a)    Anything in this Agreement to the contrary notwithstanding, if at the time of the Executive’s separation from
service within the meaning of Section 409A of the Code, the Company determines that the Executive is a “specified employee” within the meaning of Section 409A(a)(2)(B)(i) of the Code, then to the extent any payment or benefit
that the Executive becomes entitled to under this Agreement or otherwise on account of the Executive’s separation from service would be considered deferred compensation otherwise subject to the 20 percent additional tax imposed pursuant to
Section 409A(a) of the Code as a result of the application of Section 409A(a)(2)(B)(i) of the Code, such payment shall not be payable and such benefit shall not be provided until the date that is the earlier of (A) six months and one
day after the Executive’s separation from service, or (B) the Executive’s death. If any such delayed cash payment is otherwise payable on an installment basis, the first payment shall include a
catch-up payment covering amounts that would otherwise have been paid during the six-month period but for the application of this provision, and the balance of the
installments shall be payable in accordance with their original schedule. 
 (b)    All
in-kind benefits provided and expenses eligible for reimbursement under this Agreement shall be provided by the Company or incurred by the Executive during the time periods set forth in this Agreement. All
reimbursements shall be paid as soon as administratively practicable, but in no event shall any reimbursement be paid after the last day of the taxable year following the taxable year in which the expense was incurred. The amount of in-kind benefits provided or reimbursable expenses incurred in one taxable year shall not affect the in-kind benefits to be provided or the expenses eligible for reimbursement
in any other taxable year (except for any lifetime or other aggregate limitation applicable to medical expenses). Such right to reimbursement or in-kind benefits is not subject to liquidation or exchange for
another benefit. 
 (c)    To the extent that any payment or benefit described in this Agreement constitutes “non-qualified deferred compensation” under Section 409A of the Code, and to the extent that such payment or benefit is payable upon the Executive’s termination of employment, then such payments
or benefits shall be payable only upon the Executive’s “separation from service.” The determination of whether and when a separation from service has occurred shall be made in accordance with the presumptions set forth in Treasury
Regulation Section 1.409A-1(h). 
 (d)    The parties intend that this
Agreement will be administered in accordance with Section 409A of the Code. To the extent that any provision of this Agreement is ambiguous as to its compliance with Section 409A of the Code, the provision shall be read in such a manner so
that all payments hereunder comply with Section 409A of the Code. Each payment pursuant to this Agreement or the Restrictive Covenants Agreement is intended to constitute a separate payment for purposes of Treasury Regulation Section 1.409A-2(b)(2). The parties agree that this 

 
Agreement may be amended, as reasonably requested by either party, and as may be necessary to fully comply with Section 409A of the Code and all related rules and regulations in order to
preserve the payments and benefits provided hereunder without additional cost to either party. 
 (e)    The Company
makes no representation or warranty and shall have no liability to the Executive or any other person if any provisions of this Agreement are determined to constitute deferred compensation subject to Section 409A of the Code but do not satisfy
an exemption from, or the conditions of, such Section. 
 8.    Continuing Obligations.  

(a)    Restrictive Covenants Agreement. As a condition of employment, the Executive’s eligibility for pay and
benefits in Sections 5 and 6 of this Agreement, and the one-time retention bonus provided for in Section 2(f), the Executive is required to enter into the Employee Confidentiality, Assignment,
Nonsolicitation and Noncompetition Agreement, attached hereto as Exhibit A (the “Restrictive Covenants Agreement”). For purposes of this Agreement, the obligations in this Section 8 and those that arise in the Restrictive
Covenants Agreement and any other agreement relating to confidentiality, assignment of inventions, or other restrictive covenants shall collectively be referred to as the “Continuing Obligations.” 

(b)    Third-Party Agreements and Rights. The Executive hereby confirms that the Executive is not bound by the
terms of any agreement with any previous employer or other party which restricts in any way the Executive’s use or disclosure of information, other than confidentiality restrictions (if any), or the Executive’s engagement in any business.
The Executive represents to the Company that the Executive’s execution of this Agreement, the Executive’s employment with the Company and the performance of the Executive’s proposed duties for the Company will not violate any
obligations the Executive may have to any such previous employer or other party. In the Executive’s work for the Company, the Executive will not disclose or make use of any information in violation of any agreements with or rights of any such
previous employer or other party, and the Executive will not bring to the premises of the Company any copies or other tangible embodiments of non-public information belonging to or obtained from any such
previous employment or other party. 
 (c)    Litigation and Regulatory Cooperation. During and after the
Executive’s employment, the Executive shall cooperate fully with the Company in (i) the defense or prosecution of any claims or actions now in existence or which may be brought in the future against or on behalf of the Company which relate
to events or occurrences that transpired while the Executive was employed by the Company, and (ii) the investigation, whether internal or external, of any matters about which the Company believes the Executive may have knowledge or information.
The Executive’s full cooperation in connection with such claims, actions or investigations shall include, but not be limited to, being available to meet with counsel to answer questions or to prepare for discovery or trial and to act as a
witness on behalf of the Company at mutually convenient times. During and after the Executive’s employment, the Executive also shall cooperate fully with the Company in connection with any investigation or review of any federal, state or local
regulatory authority as any such investigation or review relates to events or occurrences that transpired while the Executive was employed by the Company. The Company shall reimburse the Executive for any reasonable out-of-pocket expenses incurred in connection with such cooperation, and will compensate the Executive at an hourly rate for all time spent on such matters based on the Executive’s Base Salary on the
Date of Termination. 

 (d)    Non-Disparagement.
During the Executive’s employment and following the termination of the Executive’s employment for any reason, the Executive shall not, and will not cause any third party to, publish or communicate to any person, any Disparaging remarks,
comments or statements concerning the Company, its affiliated and related entities, and its and their present and former members, partners, directors, officers, shareholders, employees, agents, legal counsel, successors and assigns. For purposes of
this Agreement, “Disparaging” shall mean remarks, comments or statements that place the person or entity being disparaged in a false or negative light or that otherwise impugn the character, honesty, integrity, morality, acumen, abilities,
conduct or operations of the person or entity being disparaged. On or following the Executive’s Date of Termination, the Company shall instruct its then-current executive officers and then-current directors not to make Disparaging remarks,
comments or statements about the Executive during the then-current executive officers and then-current directors’ employment and/or engagement with the Company; provided, however, that the foregoing does not in any way limit or modify an
officer or director’s obligations or duties (fiduciary or otherwise) to any person. Notwithstanding anything to the contrary in the foregoing, nothing in this Agreement shall be construed to (a) preclude truthful disclosures in response to
lawful process as required by applicable law, regulation, or order or directive of a court, governmental agency or regulatory organization, (b) restrict or impede the exercise of rights under Section 7 of the National Labor Relations Act,
or (c) prevent the Executive, the Company, or any other person from making truthful statements as may be reasonably required to perform such person’s duties and responsibilities on behalf of the Company, such as (for example) offering
negative performance feedback in a personnel review. 
 (e)    Relief. The Executive agrees that it would be
difficult to measure any damages caused to the Company which might result from any breach by the Executive of the Continuing Obligations, and that in any event money damages would be an inadequate remedy for any such breach. Accordingly, the
Executive agrees that if the Executive breaches, or proposes to breach, any portion of the Continuing Obligations, the Company shall be entitled, in addition to all other remedies that it may have, to an injunction or other appropriate equitable
relief to restrain any such breach without showing or proving any actual damage to the Company and without the posting of a bond. 

9.    Consent to Jurisdiction. The parties hereby consent to the jurisdiction of the state and federal courts of
the Commonwealth of Massachusetts. Accordingly, with respect to any such court action, the Executive (a) submits to the exclusive personal jurisdiction of such courts; (b) consents to service of process; and (c) waives any
other requirement (whether imposed by statute, rule of court, or otherwise) with respect to personal jurisdiction or service of process. 

10.    Waiver of Jury Trial. Each of the Executive and the Company irrevocably and unconditionally WAIVES ALL RIGHT
TO TRIAL BY JURY IN ANY PROCEEDING (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE EXECUTIVE’S EMPLOYMENT BY THE COMPANY OR ANY AFFILIATE OF THE COMPANY, INCLUDING WITHOUT LIMITATION THE
EXECUTIVE’S OR THE COMPANY’S PERFORMANCE UNDER, OR THE ENFORCEMENT OF, THIS AGREEMENT. 

 11.    Integration. This Agreement constitutes the entire
agreement between the parties with respect to the subject matter hereof and supersedes all prior agreements between the parties concerning such subject matter, including the Prior Agreement (except for the Executive’s repayment obligation with
respect to the Signing Bonus in Section 6 of the Prior Agreement shall remain in effect until March 16, 2021), provided that the Continuing Obligations, Restrictive Covenants Agreement and the Equity Documents (as modified by
Section 2(g) in this Agreement) remain in full force and effect. 
 12.    Withholding; Tax Effect. All
payments made by the Company to the Executive under this Agreement shall be net of any tax or other amounts required to be withheld by the Company under applicable law. Nothing in this Agreement shall be construed to require the Company to make any
payments to compensate the Executive for any adverse tax effect associated with any payments or benefits or for any deduction or withholding from any payment or benefit. 

13.    Assignment. Neither the Executive nor the Company may make any assignment of this Agreement or any interest
in it, by operation of law or otherwise, without the prior written consent of the other; provided, however, that the Company may assign its rights and obligations under this Agreement (including the Restrictive Covenants Agreement) without the
Executive’s consent to any affiliate or to any person or entity with whom the Company shall hereafter effect a reorganization, consolidate with, or merge into or to whom it transfers all or substantially all of its properties or assets;
provided further that if the Executive remains employed or becomes employed by the Company, the purchaser or any of their affiliates in connection with any such transaction, then the Executive shall not be entitled to any payments, benefits or
vesting pursuant to Section 5 or pursuant to Section 6 of this Agreement solely as a result of such transaction. This Agreement shall inure to the benefit of and be binding upon the Executive and the Company, and each of the
Executive’s and the Company’s respective successors, executors, administrators, heirs and permitted assigns. 

14.    Enforceability. If any portion or provision of this Agreement (including, without limitation, any portion or
provision of any section of this Agreement) shall to any extent be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder of this Agreement, or the application of such portion or provision in circumstances other
than those as to which it is so declared illegal or unenforceable, shall not be affected thereby, and each portion and provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law. 

15.    Survival. The provisions of this Agreement shall survive the termination of this Agreement and/or the
termination of the Executive’s employment to the extent necessary to effectuate the terms contained herein. 

16.    Waiver. No waiver of any provision hereof shall be effective unless made in writing and signed by the
waiving party. The failure of any party to require the performance of any term or obligation of this Agreement, or the waiver by any party of any breach of this Agreement, shall not prevent any subsequent enforcement of such term or obligation or be
deemed a waiver of any subsequent breach. 

 17.    Notices. Any notices, requests, demands and other
communications provided for by this Agreement shall be sufficient if in writing and delivered in person or sent by a nationally recognized overnight courier service or by registered or certified mail, postage prepaid, return receipt requested, to
the Executive at the last address the Executive has filed in writing with the Company or, in the case of the Company, at its main offices, attention of the Board. 

18.    Amendment. This Agreement may be amended or modified only by a written instrument signed by the Executive
and by a duly authorized representative of the Company. 
 19.    Effect on Other Plans and Agreements. An
election by the Executive to resign for Good Reason under the provisions of this Agreement shall not be deemed a voluntary termination of employment by the Executive for the purpose of interpreting the provisions of any of the Company’s benefit
plans, programs or policies. Nothing in this Agreement shall be construed to limit the rights of the Executive under the Company’s benefit plans, programs or policies except as otherwise provided in this Agreement, and except that the Executive
shall have no rights to any severance benefits under any Company severance pay plan, offer letter or otherwise. Except for the Restrictive Covenants Agreement, in the event that the Executive is party to an agreement with the Company providing for
payments or benefits under such plan or agreement and under this Agreement, the terms of this Agreement shall govern and the Executive may receive payment under this Agreement only and not both. Further, Section 5 and Section 6 of this
Agreement are mutually exclusive and in no event shall the Executive be entitled to payments or benefits pursuant to both Section 5 and Section 6 of this Agreement. 

20.    Governing Law. This is a Massachusetts contract and shall be construed under and be governed in all respects
by the laws of the Commonwealth of Massachusetts, without giving effect to the conflict of laws principles thereof. With respect to any disputes concerning federal law, such disputes shall be determined in accordance with the law as it would be
interpreted and applied by the United States Court of Appeals for the First Circuit. 
 21.    Counterparts. This
Agreement may be executed in any number of counterparts, each of which when so executed and delivered shall be taken to be an original; but such counterparts shall together constitute one and the same document. 

22.    Legal Fees. The Company will reimburse Executive up to $5,000, inclusive of applicable taxes, in respect of
legal fees incurred by him in connection with the review and execution of this Agreement. The payment will be made directly to the firm retained by Executive upon submission to the Company of any invoice reflecting the total amount due. 

 IN WITNESS WHEREOF, the parties have executed this Agreement effective on the Effective
Date. 
  

			
	FUSION PHARMACEUTICALS, INC.

 
			
		
	By:	 	  

	Its:	 	  

 
			
	
	FUSION PHARMACEUTICALS US, INC.
		
	By:	 	
	Its:	 	
	
	EXECUTIVE
	
	  

	James O’Leary

 Exhibit A 

Restrictive Covenants AgreementExhibit 10.1

 

EXCLUSIVE
Software LICENSE AND Distribution Agreement*

 

This Exclusive Software
License and Distribution Agreement (the “Agreement”) is by and among Cranes Software International Ltd., a company
organized under the laws of India (“Cranes” which expression shall include its successors and permitted assigns
wherever the context or meaning shall so require or permit), with a principal office located at # 82 Presidency Building 3 &
4th Floor St. Mark's Road Bengaluru 560001, Systat Software, Inc., a Delaware corporation (“Systat”
which expression shall include its successors and permitted assigns wherever the context or meaning shall so require or permit,
with a principal office at 2107 North First Street, Suite 360, San Jose, CA 95131 USA (Systat, Cranes and each of their direct
and indirect subsidiaries shall hereinafter be collectively referred to as the “Systat Parties”), and Inpixon,
a Nevada corporation, with a principal office at 2479 East Bayshore Road, Suite 195, Palo Alto, CA 94303 (“Inpixon”
which expression shall include its successors and assigns wherever the context or meaning shall so require or permit) with an effective
date as of June 1, 2020 (the “Effective Date”). Inpixon and the Systat Parties may be individually referred
to as a “Party” and collectively as, the “Parties”).

 

RECITALS

 

WHEREAS, the
Systat Parties own the Software, Software Source and Systat Intellectual Property;

 

WHEREAS, Systat
has certain absolute ownership, exclusive development, marketing and distribution license , along with intellectual property rights
associated with the Products (the “Rights”), including rights to sub-license the Rights associated with the
Products as set forth in this Agreement.

 

WHEREAS, Inpixon
wishes to procure from Systat Parties and Systat Parties wish to grant to Inpixon: (a) an exclusive license to use, modify, develop,
market and distribute the Software, Software Source, User Documentation and related Systat Intellectual Property; (b) an exclusive
sub-license to use, modify, develop, market and distribute Software, Software Source, User Documentation and related Intellectual
Property licensed to Systat by Cranes;

 

WHEREAS, Inpixon
also desires to obtain, and the Systat Parties wish to grant to Inpixon an option and right of first refusal to purchase the Assets;

 

WHEREAS, the
Parties are willing to enter into this Agreement under the terms and conditions set forth below.

 

NOW THEREFORE,
in consideration of the premises and the mutual covenants and agreements contained herein, the Parties hereto agree to the following
terms and conditions.

 

ARTICLE 1

DEFINITIONS

 

		1.1.	“Add-in-Module” means a separate product that Inpixon (or any direct or indirect
subsidiaries, affiliates or related parties) may develop and license that does not contain any of the Software Source but that
is linked with the Software Source through I/O Technology developed by Inpixon, or a third party working for or on behalf of Inpixon.

 

		1.2.	“Assets” means the Software, Software Source, User Documentation, Systat Intellectual
Property, Customer Information and Equipment.

 

		1.3.	“Closing Date” shall be on or about June 19, 2020, or such other date as the
Parties may agree to.

 

* Schedules,
exhibits and similar attachments have been omitted pursuant to Item 601(a)(5) of Regulation S-K and will be provided on a supplemental
basis to the Securities and Exchange Commission upon request.

 

    

     

    

 

		1.4.	“Customer Maintenance” means the service of providing licensees and end users
of the Products with technical support and Updates.

 

		1.5.	“Error” means any failure of or problem, non-conformity, defect, malfunction,
error or “bug” that causes a Product to fail to provide the performance, features and functionality described in the
User Documentation.

 

		1.6.	“Equipment” means the computer hardware and other equipment listed on Schedule
1.6 hereto.

 

		1.7.	“Governmental Authority” means: (a) any court, tribunal, judicial body
or arbitral body or arbitrator; (b) any domestic or foreign government or supranational body or authority whether multinational,
national, federal, provincial, territorial, state, municipal or local and any governmental agency, governmental authority, governmental
bureau, governmental department, governmental tribunal or governmental commission of any kind whatsoever; (c) any subdivision
or authority of any of the foregoing; (d) any quasi-governmental or private body or public body exercising any regulatory,
administrative, expropriation or taxing authority under or for the account of the foregoing; (e) any stock or securities exchange;
and (f) any public utility authority.

 

		1.8.	“Intellectual Property” means any and all rights in, arising out of, or associated
with any of the following in any jurisdiction throughout the world: (a) issued patents and patent applications (whether provisional
or nonprovisional), including divisionals, continuations, continuations-in-part, substitutions, reissues, reexaminations, extensions
or restorations of any of the foregoing, and other Governmental Authority-issued indicia of invention ownership (including certificates
of invention, petty patents and patent utility models); (b) trademarks, service marks, brands, certification marks, logos,
trade dress, trade names, and other similar indicia of source or origin, together with the goodwill connected with the use thereof,
and all registrations, applications for registration, and renewals of, and common law rights in, any of the foregoing (“Trademarks”);
(c) copyrights and works of authorship, whether or not copyrightable, and all registrations, applications for registration,
and renewals of any of the foregoing; (d) internet domain names all associated web addresses, URLs (“Domain Names”),
and related websites and web pages, and all content, software, and data thereon or relating thereto (“Websites”);
(e) mask works, and all registrations, applications for registration, and renewals thereof; (f) trade secrets, know-how,
inventions (whether or not patentable), discoveries, improvements, technology, business and technical information, databases, data
compilations and collections, tools, methods, processes, protocols, algorithms, analysis methods, scripts, test documentation,
including but not limited to, test cases, test plans, test scripts and/or harnesses, routines used to process data, techniques
and other confidential and proprietary information and all rights therein; (g) computer programs, operating systems, applications,
firmware and other code, including all Source Code, Object Code, executable code, application programming interfaces, data files,
protocols, specifications, test suites, user interfaces, programmer notes, admin rights, software support agreements, packaging,
content, graphics, artwork, audiovisual works, images, photographs, literary works, performances, music, sounds, content, user
interfaces, “look and feel,” and other documentation thereof; (h) rights of publicity; (i) all rights to
sue and recover for any past, present, or future infringement, misappropriation, or other violation of any of the foregoing, and
(j) other intellectual property rights arising under the laws of any jurisdiction throughout the world or pursuant to any
international convention.

 

		1.9.	“Inpixon Customer” means a customer that is not a customer of the Systat Parties
as of the Effective Date that purchases or licenses the Products from Inpixon or an Inpixon Subdistributor following the Effective
Date.

 

    2

     

    

 

		1.10.	“Inpixon Subdistributor” means a subdistributor that is not a subdistributor
of the Systat Parties as of the Effective Date that Inpixon engages to resell, distribute or otherwise sell the Products following
the Effective Date.

 

		1.11.	“Material Adverse Effect” means, in respect of the Systat Parties, any event,
matter, circumstance, occurrence, fact, condition or change that is, or could reasonably be expected to become, individually or
in the aggregate, materially adverse to: (a) the licenses and other rights granted pursuant to this Agreement, or the business
of the Systat Parties, results of operations, capital, condition (financial or otherwise) or assets of the Systat Parties, as applicable;
or (b) the ability of the Systat Parties, to consummate the transactions contemplated hereby.

 

		1.12.	“Object Code” means the machine readable version of applicable software generated
by a Source Code language processor such as an assembler or compiler.

 

		1.13.	“Open Source Software” means any software that meets one or more of the following
criteria: (a) has been distributed, contributed or otherwise transferred into the public domain, either voluntarily, involuntarily,
by the operation of law or otherwise, (b) is subject to, distributed, transmitted, licensed or otherwise made available under any
so-called “public license,” “open source license,” “free license,” “industry standard
license,” intellectual property pool license” or similar license, the intention of which is to permit the public use,
modification, distribution, incorporation and/or exploitation of the software without conveying an exclusive or proprietary interest
in such licensed Software (although certain other conditions may be imposed by such license), or (c) subject to, distributed, transmitted,
licensed or otherwise made available under any version of any of the following licenses: GNU General Public License, GNU Library
or “Lesser” Public License, BSD license, MIT license, Mozilla Public License, IBM Public License, Apache Software License,
Sun Industry Standards Source License, Intel Open Source License, Apple Public Source License, or any substantially similar license,
or any license that has been approved by the Open Source Initiative.

 

		1.14.	“Person” means an individual, partnership, corporation, business trust, limited
liability company, limited liability partnership, joint stock company, trust, unincorporated association, joint venture or other
entity or a Governmental Authority.

 

		1.15.	“Products” means the Software.

 

		1.16.	“Software” means individually and collectively, the current, as of the Closing
Date, Object Code version of each of the software products owned by the Systat Parties as set forth on Schedule 1.16.

 

		1.17.	“Software Source” means the Source Code for the Software, including (a) the
current, as of the Closing Date, present and pending releases of the Software, and (b) Source Code for all versions of the Software
that have been provided to any Systat Customers or Systat Subdistributors at any time prior to the Closing Date where such Software
is provided pursuant to a Systat Customer Contract or Systat Distribution Agreement, as applicable, or other Software maintenance
contract with the applicable Systat Customer or Systat Subdistributor, in each case that is effective as of the Closing Date, including
any partially completed releases and works in progress, and any supporting documentation and related technical information; and
including any other operating system for the Software developed by or on behalf of the Systat Parties over the last three years.

 

		1.18.	“Source Code” means the human readable source code of the software to which
it relates, in the programming language in which the software was written, together with all related flow charts, code and technical
documentation, including a description of the procedure for generating Object Code, all of a level sufficient to enable a programmer
reasonably fluent in such programming language to understand, build, operate, support, maintain and develop modifications, upgrades,
updates, adaptations, enhancements, new versions and other derivative works and improvements of, and to develop computer programs
compatible with, the applicable software.

 

    3

     

    

 

		1.19.	“Starcom” means Starcom Information Technology Limited, a company organized
under the laws of India and a Systat Subdistributor.

 

		1.20.	“Starcom Customer” means a customer that is party to a Starcom Customer Contract,
or that licenses or purchases the Products from a Starcom Subdistributor.

 

		1.21.	“Starcom Customer Contracts” means customer contracts in effect on the Effective
Date, to which Starcom and a Starcom Customer are a party, covering the licensing and use of the Products.

 

		1.22.	“Starcom Distribution Agreement(s)” means all reseller, development and distribution
contracts in effect as of the Effective Date, to which each of Starcom and a Starcom Subdistributor are a party, covering the resale,
distribution and sale of the Products.

 

		1.23.	“Starcom Subdistributor” means a reseller or subdistributor that is party to
a Starcom Distribution Agreement.

 

		1.24.	“Systat Customer” means a Starcom Customer or any other customer that is party
to a Systat Customer Contract or a Starcom Customer Contract that is assigned to, and assumed by, Inpixon in accordance with the
terms set forth herein, or that licenses or purchases the Products from a Systat Subdistributor.

 

		1.25.	“Systat Customer Contracts” means customer contracts in effect on the Effective
Date, to which any of the Systat Parties and a Systat Customer or Starcom and a Systat Customer are a party, covering the licensing
and use of the Products.

 

		1.26.	“Systat Disclosure Schedules” means the schedules attached to this Agreement
delivered by the Systat Parties prior to the execution and delivery of this Agreement.

 

		1.27.	“Systat Distribution Agreement(s)” means all Starcom Distribution Agreement(s)
and any other reseller, development and distribution contracts in effect on the Effective Date, to which each of a Systat Party
and a Systat Subdistributor or Starcom are a party, covering the resale, distribution and sale of the Products.

 

		1.28.	“Systat Intellectual Property” means the Intellectual Property used or held
for use by the Systat Parties in connection with the Assets as of the Closing Date, including, without limitation, the Software,
the Systat Proprietary Technology, the Systat Trademarks, the Systat Websites and all other Intellectual Property set forth on
Schedule 1.28 hereto.

 

		1.29.	“Systat Customer Service Numbers” means the phone numbers set forth on Schedule
1.29.

		1.30.	“Systat Proprietary Technology” means all proprietary data formulae, including
proprietary software algorithms for all of the statistical analysis methods embodied in the Products  and algorithmic processes
and proprietary data flow diagrams for all of the statistical analysis methods embodied in the Products.

 

		1.31.	“Systat SigmaPlot Agreements” means all agreements in effect as of the Effective
Date pursuant to which Cranes has granted Systat with the right to license, distribute, develop, manufacture or exploit the Software
set forth on Schedule 1.16 owned by Cranes (“SigmaPlot Software”), in anyway, including but not limited to the
agreements set forth on Schedule 1.31.

 

    4

     

    

 

		1.32.	“Systat Subdistributor” means a reseller or subdistributor that is party to
a Systat Distribution Agreement that is assigned to, and assumed by, Inpixon in accordance with the terms set forth herein.

 

		1.33.	“Systat Trademarks” means the Trademarks set forth on Schedule 1.33 owned
by the Systat Parties or which the Systat Parties have the right to sublicense for use by third parties in relation to the Products.

 

		1.34.	“Systat Websites” means the Websites and Domain Names constituting Systat Intellectual
Property and set forth on Schedule 1.34, including, for the avoidance of doubt, all content and data thereon or relating
thereto and all Intellectual Property incorporated therein.

 

		1.35.	“Tax” and “Taxes” shall mean all forms of taxation including
withholding tax or cess, duties, GST, imposts, levies, fees, charges, social security contributions and rates imposed, levied,
collected withheld or assessed as a tax (direct or indirect) under any tax legislation by any local, municipal, governmental, state,
central or other body in India or any other state, county, local, municipal or foreign Governmental Authority or subdivision or
agency thereof or elsewhere and any interest, additional taxation penalty, surcharge or fine in connection therewith.

 

		1.36.	“Territory” means worldwide.

 

		1.37.	“Third Party Technology” means all Intellectual Property, including, without
limitation, software, content, tools, or other technology of any kind, provided by the Systat Parties as part of the Products and/or
Assets, including any Intellectual Property embedded or incorporated in the Products and/or Assets, that is not solely owned by
a Systat Party as set forth on Schedule 2.7 A and Schedule 2.7(B) hereto.

 

		1.38.	“Transaction Documents” means this Agreement, the License Note Assignment, the
Intercreditor Agreement, the Starcom Termination Agreement and any other Exhibits or Schedules hereto or thereto and any other
documents or agreements executed in connection herewith or therewith (other than the Software License Form).

 

		1.39.	“Updates” means all enhancements, upgrades, modifications, improvements, corrections,
revisions, Error corrections, and/or new versions or releases of the Products and/or User Documentation.

 

		1.40.	“User Documentation” means the current, as of the Closing Date, version of documents
that describes the function and use of the Products and including documentation intended for distribution to licensees of the Products,
including, all materials supplied by the Systat Parties to Inpixon, whether in printed or electronic form, via any media or mode
of communication, that explain or facilitate the use of the Products, including, without limitation, users’ manuals, release
notes, specifications, requirements, customer notices, operational manuals, instructions, training materials, flow charts, diagrams,
systems manuals, programming manuals, modification manuals, Product development roadmaps and any derivative works created by the
Systat Parties that include product images, including screenshots of the product, images or text from Systat Parties’ materials,
as well as any notes, memoranda, or communication, created by Systat Parties or its subdistributors in any media that describe
or summarize the Products.

 

		1.41.	“I/O Technology” means software that links the Software Source and any Add-In-Module.

 

    5

     

    

 

ARTICLE 2

LICENSE GRANT; SOFTWARE MODIFICATION
RIGHTS; CUSTOMER AND DISTRIBUTION CONTRACTS

 

		2.1.	Term of License Grant. The licenses granted pursuant to this Article 2 and the obligations
of Inpixon arising in connection therewith shall be deemed effective as of the Effective Date and shall continue for a term of
fifteen (15) years from the Closing Date, until terminated pursuant to the terms set forth in Article 5 (the “License
Term”).

 

		2.2.	License Grant. Subject to the provisions contained herein, Systat grants to Inpixon the
exclusive, fully transferable, royalty-free license in the Territory for the License Term to:

 

(a)
Market, promote, distribute, sell, import, export, and sublicense the Products and User Documentation, including any modified
versions thereof, and identify itself as the licensor and provider of the Products and User Documentation. Inpixon shall
distribute the Products pursuant to a sublicense agreement, either included with the Products or otherwise, that is
substantially similar to the license the Systat Parties are using as of the Effective Date with respect to granting licenses
to the Products to customers, in substantially the form included as Exhibit A hereto, including any mutually agreed
upon modifications thereto (the “Software License Form”).

 

(b) Integrate, incorporate and otherwise bundle any or all of the Products with other
Inpixon or third party products licensed, distributed or sold by Inpixon, and market and sublicense the Products and Systat
Intellectual Property as integrated, incorporated, or bundled with such other Inpixon or third party products.

 

(c)
Provide Customer Maintenance to Inpixon Customers, Inpixon Subdistributors, Systat Customers, and Systat Subdistributors.

 

(d)
Provide Updates to the Products and User Documentation in connection with Customer Maintenance.

 

(e) Use
the Products, Systat Intellectual Property and User Documentation for its own internal purposes including demonstration
testing, promotion and evaluation.

 

(f)
Duplicate copies of the Products and User Documentation for the uses set forth in this Agreement, provided that each such
copy shall include an appropriate copyright notice. All such duplication shall be the responsibility of Inpixon.

 

(g)
Sublicense the Products, Systat Intellectual Property and User Documentation, including the right to provide any associated
Customer Maintenance, to third parties, including without limitation any of Inpixon’s direct or indirect subsidiaries,
affiliates or related parties, and/or any resellers, distributors, industry solution providers, or product integrators, who
may in turn further sublicense and/or use the Products or any copies of the Products, and provide Customer Maintenance in
each case pursuant to agreements in such form as Inpixon shall determine to be appropriate in its sole and absolute
discretion.

 

    6

     

    

 

		2.3.	Software Modifications.

 

(a)
Systat hereby grants Inpixon an exclusive, fully transferable, royalty-free license in the Territory for the License Term, to
use the Software Source in order to create derivative works and improvements and make modifications, enhancements, changes,
or corrections to the Software, Systat Intellectual Property and Software Source (collectively, “Software
Modifications”), in each case as determined necessary or appropriate by Inpixon in its sole discretion. The
foregoing right and license shall include the right for any of Inpixon’s direct or indirect subsidiaries, affiliates or
related parties to create Software Modifications, and for Inpixon to enter into agreements with third-party commercial
software vendors or third-party software consultants Inpixon deems necessary for new product innovations. Inpixon shall have
the right to use and exploit the Software Modifications as determined in Inpixon’s sole discretion, including in
connection with the Products, or Inpixon or third party products licensed, distributed, or sold by Inpixon.

 

(b)
Subject to the Systat Parties’ retained rights in the Software, Software Source and Systat Intellectual Property, as
set forth in Section 2.16, Inpixon shall solely and exclusively own all right, title and interest in and to the Software
Modifications and the Source Code associated with any Software Modifications. To the extent that, by operation of law, any
rights in any applicable Software Modifications are deemed to vest in the Systat Parties, each of the Systat Parties hereby
agrees to assign and hereby assigns to Inpixon all of its right, title and interest in and to each such Software Modification
and all Intellectual Property embodied in each such Software Modification. To the extent that, by operation of law, the
foregoing assignment and agreement to assign is not effective with respect to any rights of the Systat Parties, each of the
Systat Parties hereby agrees to grant and hereby grants to Inpixon a royalty-free, fully paid-up, exclusive (even as to the
Systat Parties), perpetual, irrevocable, worldwide right and license to exploit any and all of each applicable Systat
Party’s rights in each such Software Modification, and each of the Systat Parties agrees not to assert against Inpixon
or those taking under its authority any inalienable rights it has or may come to have in any such Software Modification. Upon
the request of Inpixon, the Systat Parties shall promptly take such reasonable further actions, including execution and
delivery of all appropriate instruments of conveyance, as may be necessary to assist Inpixon to prosecute, register, perfect,
record or enforce its rights in any Software Modifications. In addition, Inpixon shall retain sole and exclusive ownership,
and all right, title, and interest, both legal and equitable, in and to the Add-In-Module and I/O Technology.

 

(c) At
its option and in its sole and absolute discretion, any time during the License Term or upon termination of this Agreement in accordance
with the provisions of Article 7, Inpixon may offer the Systat Parties a non-exclusive license to use, market, and distribute the
Software (subject to Inpixon’s exclusive rights hereunder) with the Software Modifications owned by Inpixon upon such terms
and conditions as the Parties may agree.

 

		2.4.	Acceptance Testing. On or promptly following the Effective Date, the Systat Parties shall
deliver to Inpixon, in the form and format as shall be agreed to by the Parties, copies of the Products and all related Software
Source and User Documentation. The Systat Parties acknowledge that the Products and Software Source will be subject to acceptance
testing by Inpixon in accordance with the procedures set forth in this Section 2.4. Following delivery of the Products, and all
related Software Source and User Documentation, Inpixon shall have a period of up to ten (10) business days to review the Products
and Software Source to ensure they conform to the User Documentation. If the Products and/or Software Source fails to conform to
the User Documentation in any material respect, as determined by Inpixon in its reasonable discretion, Inpixon will furnish the
Systat Parties with a reasonably detailed report that identifies the specific defects in the Products and/or Software Source (a
“Defect Report”), and, if applicable, the modifications to the Products and/or Software Source that need to
be made in order for the Products and/or Software Source to conform to the User Documentation. Upon receipt of a Defect Report,
the Systat Parties shall have ten (10) business days to modify the Products and/or Software Source in accordance with the Defect
Report and re-submit the Products and/or Software Source to Inpixon for review in accordance with the terms of this Section 2.4.
The foregoing procedure will repeat until Inpixon finally accepts or finally rejects the Products and/or Software Source. If the
Systat Parties are unable to remedy the relevant defect(s) after three attempts, Inpixon may, upon written notice to the Systat
Parties, immediately terminate this Agreement in its entirety, in which event Systat Parties shall refund to Inpixon all consideration,
if any, paid to the Systat Parties by Inpixon prior to the date of termination and all rights with regard to the Products that
may have been granted or transferred pursuant to this Agreement shall automatically revert to the respective Systat Parties, which
shall be Inpixon’s sole remedy and Systat Parties’ sole liability in any such case.

 

    7

     

    

 

		2.5.	Inpixon Obligations. In connection with the rights granted by Systat to Inpixon pursuant
to Section 2.2, above, throughout the License Term, Inpixon shall:

 

(a) be
responsible for marketing and licensing the Products and User Documentation;

 

(b) be
responsible for duplicating and manufacturing the Products and User Documentation and for all costs associated with such responsibilities.
Inpixon shall also be responsible for shipping the Products to Inpixon’s customers and for all costs associated with such
responsibilities;

 

(c)
have the right to determine the packaging and the pricing of the Products; and

 

(d)
provide direct technical support and Customer Maintenance to all Inpixon Customers, Inpixon Subdistributors, Systat
Customers, and Systat Subdistributors. All Customer Maintenance with respect to those Systat Customer Contracts assumed by
Inpixon in accordance with Section 2.12 of this Agreement shall be provided by Inpixon; provided, that, if Inpixon is unable
to provide such Customer Maintenance due to restrictions or requirements of applicable laws and regulations in the Territory,
or for other reasons as determined by Inpixon in its sole discretion, Systat shall continue to provide such Customer
Maintenance for the remaining term of the applicable Systat Customer Contract, and in such event, notwithstanding the
exclusive nature of the licenses granted hereunder, Systat shall have the right to use the Products, User Documentation,
Software Source and Systat Intellectual Property solely for purposes of providing such Customer Maintenance as required
pursuant to the applicable Systat Customer Contract. The Systat Parties shall be required to provide such Customer
Maintenance unless the Systat Parties are unable to provide such Customer Maintenance solely due to restrictions or
requirement of applicable laws or regulations in the Territory, or because the technology personnel required to perform such
Customer Maintenance are no longer employed or engaged by the Systat Parties. If neither Inpixon nor the Systat Parties are
able to provide Customer Maintenance in connection with an applicable Systat Customer Contract, the Systat Parties shall be
responsible for refunding to the applicable Systat Customer all amounts paid by the applicable Systat Customer with respect
to Customer Maintenance, or such other amounts as may be required to compensate the Systat Customer in accordance with the
applicable Systat Customer Contract.

 

		2.6.	Trademark License. Systat hereby grants to Inpixon an exclusive, non-transferable, sublicenseable,
royalty free, license in the Territory for the License Term, to use and sublicense the Systat Trademarks for all purposes related
to Inpixon’s exercise of its rights and performance of its obligations pursuant to this Agreement, including to market, advertise
and distribute the Products and any Software Modifications relating thereto. If Inpixon applies the Systat Trademarks to the Products,
User Documentation or other materials which were not created entirely by any of the Systat Parties, such Software User Documentation
or other materials shall conform to reasonable quality standards, if any, that are provided to Inpixon by the Systat Parties during
the License Term. Such quality standards shall be no more stringent than the quality standards applicable to Systat’s use
of the Systat Trademarks in connection with the Products in the Territory prior to the Effective Date. If Inpixon’s use of
the Systat Trademarks does not meet such quality standards, Systat may require that Inpixon remove the Systat Trademarks from the
applicable Products, User Documentation or other materials, provided, that the foregoing shall not be deemed to limit Inpixon’s
rights set forth in Sections 2.2 and 2.3, and Inpixon shall have the right to use Inpixon’s own Trademarks in connection
with the applicable Products and User Documentation. All goodwill associated with Inpixon’s use of the Systat Trademarks
shall inure to the benefit of Systat. Notwithstanding the foregoing, Inpixon shall not be obligated to use the Systat Trademarks
in connection with the Products, User Documentation and/or Software Modifications, and Inpixon shall have the right to use its
own branding in connection therewith in its sole discretion.

 

    8

     

    

 

		2.7.	Third Party Technology. The rights set forth in Section 2.3 above do not apply to the Third
Party Technology. Schedule 2.7(A) sets forth a complete and accurate list of all applicable Third Party Technology which
the Systat Parties shall have responsibility for licensing and maintaining throughout the Term (the “Systat Third Party
Technology”), and the Systat Parties represent, warrant that they have, and covenant that they will maintain throughout
the License Term, all necessary rights and licenses in and to the Systat Third Party Technology as necessary to grant Inpixon the
rights and licenses granted pursuant to this Section 2.7 without restriction; provided, that, following the Closing Date, all costs
and expenses relating to maintaining all applicable rights in the Systat Third Party Technology, to the extent set forth on Schedule
2.7(A), shall be the sole and exclusive responsibility and obligation of Inpixon. With respect to the Systat Third Party Technology,
Systat hereby grants to Inpixon a non-exclusive, royalty-free, fully paid-up, transferable license in the Territory to market,
use, sublicense, sell, demonstrate, evaluate and duplicate the Object Code version of such Systat Third Party Technology as an
integral part of, or otherwise as necessary for Inpixon to exercise the rights granted to it hereunder with respect to, the Products
during the License Term. Systat shall remain the contracting party with the owners or providers of the existing Systat Third Party
Technology specified in Schedule 2.7(A); provided that Inpixon shall be responsible for paying any royalties, fees, or other
compensation due to the third-party owners or providers of the Systat Third Party Technology after the Closing Date to the extent
set forth on Schedule 2.7(A). If requested by Inpixon, Systat shall use all commercially reasonable efforts to assist Inpixon
in renegotiating new licensing terms with the owners or providers of the Systat Third Party Technology. Schedule 2.7(B)
sets forth a complete and accurate list of all applicable Third Party Technology which Inpixon shall have responsibility for licensing
and maintaining throughout the Term (the “Inpixon Third Party Technology”), and all costs and expenses relating
to maintaining all applicable rights in the Inpixon Third Party Technology shall be the sole and exclusive responsibility and obligation
of Inpixon; provided, that the Systat Parties shall continue to license and maintain the Inpixon Third Party Technology until such
time that Inpixon notifies the Systat Parties that the Systat Parties may discontinue such licensing and maintenance of the Inpixon
Third Party Technology. The Systat Parties shall provide such support and assistance as may be requested by Inpixon to facilitate
the transition of the licensing and maintenance of the Inpixon Third Party Technology to Inpixon. Nothing in this paragraph shall
preclude Inpixon from adding additional third party Intellectual Property to the Software so long as Inpixon contracts and pays
for such third party Intellectual Property.

 

		2.8.	Management and Control of Systat Websites and Systat Customer Service Numbers.

 

		a.	Promptly following the Closing Date, Systat Parties shall transfer control and management of the
Systat Websites to Inpixon, and, throughout the License Term, Inpixon or its authorized representatives shall solely control and
manage the Systat Websites, including hosting the Systat Websites and taking responsibility for all back end and front end administrative
control and management of the Systat Websites, at Inpixon’s own expense; provided, that Systat Parties shall continue to
host, or cause to be hosted, the Systat Websites until such time that the Systat Parties have transferred full control of the Systat
Websites to Inpixon in accordance with this Section 2.8, and Systat shall provide such other support to Inpixon with respect to
the Systat Websites as may be requested by Inpixon throughout the License Term. Promptly following the Effective Date, the Systat
Parties shall add, or cause to be added, Inpixon, or its designated representatives, as the sole administrator(s) of each Domain
Name associated with the Systat Websites as of the Closing Date. Systat acknowledges and agrees that as of the Closing Date and
through the License Term, Inpixon shall be responsible for maintaining the registration of the applicable Domain Names in full
force and effect with the current registrar of the applicable Domain Names, at Inpixon’s own expense.

 

    9

     

    

 

		b.	In addition to the Systat Websites, promptly following the Closing Date, Systat shall transfer
control and management of the Systat Customer Service Numbers to Inpixon and, throughout the License Term, Inpixon or its authorized
representatives shall solely maintain and operate the Systat Customer Service Numbers at Inpixon’s own expense; provided
that Systat shall provide such support to Inpixon with respect to the Systat Customer Service Numbers as may be requested by Inpixon
throughout the License Term.

 

		c.	Following the Effective Date, Systat shall reasonably cooperate with Inpixon in technical and other
preparations as necessary for the commencement of transferring control and management of the Systat Websites and Systat Customer
Service Numbers to Inpixon, and, shall take such actions and furnish and execute such additional documents and information as Inpixon
may require to effectuate and establish Inpixon’s control and management of the Systat Websites and Systat Customer Service
Numbers no later than the Closing Date. In connection with the transfer and transition of the Systat Websites and Systat Customer
Services Numbers to Inpixon, Systat shall ensure that access to the Systat Websites and Systat Customer Service Numbers shall be
uninterrupted, and Systat shall take such measures as necessary to ensure that such transfer and transition does not negatively
impact any services provided to Systat Customers and Systat Subdistributors. Following the Closing Date, Systat shall not take
any action with respect to the Systat Websites or Systat Customer Service Numbers, except as permitted hereunder or otherwise pursuant
to the written request of, or authorization from, Inpixon.

 

		2.9.	Use of Equipment. On or prior to the Closing Date, and for a period of six (6) months thereafter
or such later term as the Parties may agree, the Systat Parties shall provide the Equipment to Inpixon at no additional charge
to Inpixon, and Inpixon shall be entitled to use the Equipment as it determines necessary to exercise the rights granted to it
hereunder. Inpixon shall at all times when the Equipment is in its custody, be responsible for the safe custody thereof and shall
also be responsible for keeping and maintaining all such Equipment in a good condition, subject to ordinary wear and tear. Except
as otherwise agreed to by the Parties in writing, all Equipment shall remain the property of the Systat Parties or its applicable
third party providers.

 

		2.10.	Exclusivity Obligations; No Use by Systat Parties. Each of the Systat Parties acknowledges,
agrees and covenants that the licenses granted pursuant to Sections 2.2 and 2.3 are exclusive even as to the Systat Parties, and
during the License Term, except as permitted in Section 2.5(d) herein, none of the Systat Parties, including any direct or indirect
subsidiaries, affiliates or related parties, will, directly or indirectly, on its own behalf or with respect to any third party,
use, modify, enhance, distribute, market, sell, license, assign, transfer, commercialize or exploit in any manner the Products,
Systat Intellectual Property or Software Source in the Territory. A violation of the restrictions set forth in this Section 2.10
shall constitute a material breach of this Agreement by the Systat Parties.

 

    10

     

    

 

		2.11.	Customer Revenue. The Systat Parties agree that Inpixon is entitled to, and the Systat Parties
will deliver to Inpixon within ten days following the Systat Parties’ receipt of, any Customer Maintenance revenue, new license
fees, or license renewal fees, received by any of the Systat Parties that are paid after the Effective Date in connection with
the Systat Customer Contracts and/or Systat Distribution Agreements assigned to and assumed by Inpixon pursuant to this Agreement
(collectively, “Inpixon Revenue”). Inpixon Revenue shall include, without limitation, any revenue or license
fees in respect of any customer purchase order or statement of work received by any of the Systat Parties following the Effective
Date under the Systat Customer Contracts and/or Systat Distribution Agreements assigned to and assumed by Inpixon pursuant to this
Agreement, but shall exclude revenue received or license fees with respect to any customer purchase order or statement of work
received by any of the Systat Parties prior to the Effective Date. On or prior to the Closing Date, the Systat Parties will deliver
a list that identifies the customer, purchase order or statement of work date, and amount payable in connection with any purchase
orders or statement of works received by the Systat Parties following the Effective Date which shall set forth the amount of Inpixon
Revenue since the Effective Date. If Inpixon becomes aware of any Inpixon Revenue received by Systat and not delivered by Systat
to Inpixon as required hereby, then in addition to being entitled to the fees described below in this Section 2.11, Inpixon may
also, in its discretion, exercise the Offset Right and apply the Offset Procedure (each as defined in Section 7.2) hereof as to
the amount of any such Inpixon Revenue not delivered by Systat as required herein. Within ten (10) business days of a request from
Inpixon, Systat shall furnish to Inpixon all bank and accounting statements as may be reasonably requested by Inpixon to evidence
and verify Inpixon Revenue received by Systat and payable to Inpixon pursuant to this Section 2.11. In addition, upon ten (10)
business days’ notice to Systat, Inpixon shall have the right to audit Systat’s books and records to verify the Inpixon
Revenue and confirm Systat’s compliance with this Section 2.11. Such audits shall occur during regular business hours at
the sole cost of Inpixon and shall be conducted in a manner designed to limit disruption and avoid undue disruption to Systat’s
business. Systat shall render reasonable cooperation to Inpixon as requested by Inpixon. In the event an audit reveals that Systat
failed to pay any Inpixon Revenue payable to Inpixon hereunder, Systat shall immediately pay such Inpixon Revenue to Inpixon, and
if such underpayment was greater than five percent (5%) of the Inpixon Revenue owed to Inpixon as of the date of the audit, Systat
shall reimburse Inpixon for its costs of conducting the audit.

 

		2.12.	Customer Contracts. Inpixon shall have the right, but not the obligation, to assume all
of the Systat Parties’ rights, interests, and obligations under the Systat Customer Contracts (the “Customer Contract
Assumption Right”). If Inpixon does not exercise the Customer Contract Assumption Right, the applicable Systat Customer
Contracts shall be terminated by the Systat Parties immediately, or as soon as contractually permitted, which termination shall
be effective as of the Closing Date, and the Systat Parties shall take such actions and furnish and execute such additional documents
and information as Inpixon may require to effectuate the termination of all such Systat Customer Contracts. Notwithstanding Inpixon’s
exercise of the Customer Contract Assumption Right, Inpixon shall not assume and shall not be responsible to pay, perform or discharge
any debts, liabilities or obligations of any kind, including refunds, that arose in connection with each applicable Systat Customer
Contract prior to the Closing Date or arise following the Closing Date with respect to actions or matters that occurred prior to
the Closing Date and the Systat Parties shall be responsible for all such obligations. Except as otherwise limited or prohibited
by the terms of an applicable Systat Customer Contract or applicable law, with respect to each Systat Customer Contract that Inpixon
elects to assume pursuant to the Customer Contract Assumption Right, each such Systat Customer Contract shall be deemed to be assigned
to Inpixon by Systat, and assumed by Inpixon, and Systat hereby assigns each such Systat Customer Contract and all of its rights
and obligations thereunder, and Inpixon hereby assumes each such Systat Customer Contract and all of Systat’s rights and
obligations thereunder, as of the Closing Date, without any further action required on the part of Systat or Inpixon.

 

    11

     

    

 

		2.13.	Reseller, Development and Distribution Agreements. Inpixon shall have the right, but not
the obligation, to assume all of the Systat Parties’ rights, interests, and obligations under the Systat Distribution Agreements
(the “Distribution Contract Assumption Right”). If Inpixon does not exercise the Distribution Contract Assumption
Right, all applicable Systat Distribution Agreements for the Products, Software Source, User Documentation and Systat Intellectual
Property then in effect shall be terminated by the Systat Parties immediately, or as soon as contractually permitted, which termination
shall be effective as of the Closing Date, and the Systat Parties shall take such actions and furnish and execute such additional
documents and information as Inpixon may require to effectuate the termination of all such Systat Distribution Agreements. Notwithstanding
Inpixon’s exercise of the Distribution Contract Assumption Right, Inpixon shall not assume and shall not be responsible to
pay, perform or discharge any debts, liabilities or obligations of any kind that arose in connection with each applicable Systat
Distribution Agreement prior to the Closing Date or arise following the Closing Date with respect to actions or matters that occurred
prior to the Closing Date and the Systat Parties shall be responsible for all such obligations. Except as otherwise limited or
prohibited by the terms of an applicable Systat Distribution Agreement or applicable law, with respect to each Systat Distribution
Agreement that Inpixon elects to assume pursuant to the Distribution Contract Assumption Right, each such Systat Distribution Agreement
shall be deemed to be assigned to Inpixon by Systat, and assumed by Inpixon, and Systat hereby assigns each such Systat Distribution
Agreement and all of its rights and obligations thereunder, and Inpixon hereby assumes each such Systat Distribution Agreement
and all of Systat’s rights and obligations thereunder, as of the Closing Date, without any further action required on the
part of Systat or Inpixon. Notwithstanding the foregoing, the Systat SigmaPlot Agreements shall continue to remain in full force
and effect at all times during the License Term, subject however to the condition that such provision(s) are not in variance with
the provisions of this Agreement; and in case, if there exist any such conflicting provision(s), such provision(s) shall be deemed
to have been amended and modified, so as to align to them with the understanding provided under this Agreement without any requirement
of executing any amendment agreement to the Systat SigmaPlot Agreements.

 

		2.14.	Delayed Assignment and Assumption of Agreements. If and to the extent that the valid and
complete transfer or assignment to, or assumption by, Inpixon of any the of Systat Customer Contracts or Systat Distributor Agreements
requires any notifications, approvals or other acts or documentation that have not been obtained or completed by the Closing Date
then, unless the Parties mutually agree otherwise, the transfer or assignment to Inpixon of the applicable Systat Customer Contracts
and/or Systat Distributor Agreements, as the case may be, shall be automatically deemed deferred and any such purported transfer,
assignment or assumption shall be null and void until such time as all applicable notifications, approvals or other acts or documentation
have been obtained or completed; provided, however, that Inpixon shall be entitled to a delayed assignment fee equal to 5% of the
value of the anticipated revenue to be derived from the applicable Systat Customer Contract or Systat Distributor Agreement per
each month for which such assignment is not effective due to the failure to obtain any required notification, approval or other
acts or documentation, to the extent that the same is attributable to any of the Systat Parties and not due to Inpixon. If any
transfer or assignment of any Systat Customer Contracts and/or Systat Distributor Agreements intended to be transferred, assigned
or assumed hereunder, as the case may be, is not consummated on or prior to the Closing Date then, insofar as reasonably possible
and subject to applicable law, the Systat Parties shall be responsible for performing all applicable obligations under the applicable
Systat Customer Contracts and/or Systat Distributor Agreements on behalf of, and for the benefit of, Inpixon. The Systat Parties
shall perform all such obligations in the ordinary course of business in accordance with past practice, and shall take such other
actions as may be reasonably requested by Inpixon, in order to place Inpixon in a substantially similar position as if such Systat
Customer Contracts and/or Systat Distributor Agreements had been transferred, assigned or assumed as of the Closing Date.

 

    12

     

    

 

		2.15.	Maintenance and Enforcement of Systat Intellectual Property. The Systat Parties, at their
sole cost and expense, shall file, prosecute, and maintain all IP Registrations at all times throughout the License Term and shall
provide to Inpixon on a quarterly basis, or otherwise upon Inpixon’s request, all documentation and updates, if any, regarding
the status of the IP Registrations, and any action taken by the Systat Parties’ in connection therewith, during the immediately
prior quarter. However, in the event that the Systat Parties elect not to, or fail to, file, prosecute or maintain any of the IP
Registrations, Inpixon may elect to continue prosecution or maintenance of the applicable IP Registration, at the Systat Parties’
sole cost and expense, and any amounts expended by Inpixon in connection therewith shall be reimbursed to Inpixon by the Systat
Parties. The Systat Parties shall provide such assistance to Inpixon as may be requested by Inpixon in order for Inpixon to take
responsibility for prosecuting and maintaining the applicable IP Registrations. However, in the event the Systat Parties are unable
or unwilling to provide such assistance, each of the Systat Parties hereby irrevocably designates and appoints Inpixon and its
duly authorized officers and agents as such Systat Party’s agent and attorney-in-fact, to act for and on such Systat Party’s
behalf solely to execute and file any such application or other document and do all other lawfully permitted acts to further the
prosecution and maintenance of the IP Registrations with the same legal force and effect as if the applicable Systat Party had
executed them. The Systat Parties agree that this power of attorney is coupled with an interest. The Parties further agree that
such Power of Attorney shall automatically terminate upon the expiry or termination of this Agreement. In the event of infringement
of any rights in the Systat Intellectual Property, the Parties shall confer to determine the best way to abate the infringement;
provided, that if requested by Inpixon, the Systat Parties shall undertake enforcement of the Systat Intellectual Property, at
the Systat Parties’ sole cost and expense. If requested by the Systat Parties, Inpixon agrees to join any litigation initiated
by the Systat Parties relating to infringement of the Systat Intellectual Property, at the Systat Parties’ sole cost and
expense, and agrees to submit to the personal jurisdiction of the relevant courts.

 

		2.16.	Retention of Rights. Except for the rights and licenses granted to Inpixon under this Section
2, and subject to Article 4, the Systat Parties retain all right, title, and interest in and to the Products, Software Source,
and User Documentation, and Inpixon will have no other right, title or interest therein, whether express or implied.

 

ARTICLE 3

CONSIDERATION

 

		3.1.	Consideration and Assignment. In consideration of the rights granted by Systat to Inpixon
pursuant to this Agreement, Inpixon shall deliver the following consideration to Systat (the “Total Consideration”):

 

(a) Two
Million Two Hundred Thousand Dollars (USD $2,200,000 Million) in cash (the “Cash Consideration”) payable by
wire transfer of immediately available funds to an account to be designated by Systat on or before the Closing Date.

 

(b) An
assignment of a portion of that certain promissory note held by Inpixon and payable to Inpixon by Sysorex, Inc. (“Sysorex”),
for up to an aggregate principal amount of Six Million Three Hundred Thousand Dollars (USD $6,300,000) (the “Note”),
including the underlying rights and obligations of Inpixon under the Note, in accordance with the terms and conditions of the assignment
agreement in substantially the form attached hereto as Exhibit B (“License Note Assignment”) and the
intercreditor agreement in substantially the form attached hereto as Exhibit C (the “Intercreditor Agreement”)
as follows:

 

		(i)	$3.0 million on the Closing Date;

 

		(ii)	$1.3 million on the three month anniversary of the Closing Date;

 

		(iii)	$1.0 million on the six month anniversary of the Closing Date; and

 

		(iv)	$1.0 million on the nine month anniversary of the Closing Date.

 

    13

     

    

 

		3.2	Adequacy of Consideration.
The Parties hereby agree that the Total Consideration represents adequate consideration and that no additional consideration shall
be paid by Inpixon to Systat or any of the Systat Parties for the licenses and rights granted to Inpixon pursuant to this Agreement.

 

ARTICLE 4

PURCHASE OPTION

 

		4.1	Purchase Option. The Systat Parties hereby grant to Inpixon an option to purchase all of
the Systat Parties’ right, title and interest in and to the Assets (the “Purchase Option”) for consideration
consisting of an assignment of an additional portion of the Note in an aggregate principal amount of One Million Dollars (USD $1,000,000)
(the “Option Purchase Price”), including the underlying rights and obligations of Inpixon under the Note, subject
to the provisions of Section 4.3(b) of this Agreement.

 

		4.2	Option Term. Unless otherwise terminated pursuant to Section 5 hereof, Inpixon’s right
to exercise the Purchase Option shall commence on the Closing Date and shall expire on the five 5 year anniversary of the Closing
Date (the “Option Term”).

 

		4.3	Exercise of Purchase Option. Inpixon shall exercise the Purchase Option on or prior to the
end of the Option Term by tendering to the Systat Parties the following:

 

(a)
a written notice of Inpixon’s election to exercise the Purchase Option:

 

(b)
within thirty (30) days following the exercise of the Purchase Option, a duly executed Asset Purchase Agreement and Bill of
Sale (the “Asset Purchase Agreement”) which shall provide for (i) the payment of the Option Purchase
Price, by delivery of a duly executed assignment of the Note, on terms and conditions that are substantially similar to the
terms and conditions of the License Note Assignment (the “Asset Note Assignment”), or in the event that
the Systat Parties cannot accept the Asset Note Assignment as consideration for the purchase of the Assets due to legal or
other regulatory restrictions, in cash by wire transfer of immediately available funds to such account(s) that may be
designated by the Systat Parties, provided, however, that the Option Purchase Price shall only be satisfied in cash for such
portion of the Assets that may not be accepted by the Asset Note Assignment due to legal or regulatory restrictions and (ii)
such other customary terms and conditions as the Parties shall determine to be necessary or advisable for a transaction of
this nature and agreed by the Parties.

 

(c)
For the avoidance of doubt, the transfer of the Assets upon exercise of the Purchase Option will be governed by the Asset
Purchase Agreement.

 

		4.4	Purchase Option Termination. In accordance with Section 5.2 herein, upon termination of
this Agreement, the Purchase Option shall lapse.

 

ARTICLE 5

Termination

 

		5.1	This Agreement may be terminated as follows:

 

(a) by
mutual written consent of Systat and Inpixon;

 

    14

     

    

 

(b) by
Systat, if Inpixon fails to deliver the Total Consideration in accordance with Section 3.1 of this Agreement, and such
failure shall not have been cured within ninety (90) days after written notice thereof shall have been received by
Inpixon;

 

(c) by
Inpixon if Systat commits a breach of any provision of the Transaction Documents and such breach shall not have been cured
within thirty (30) days after written notice thereof shall have been received by Systat and

 

(d) by
Inpixon, any time prior to the Closing Date, if it is not satisfied, acting reasonably, with the results of the due diligence
review and investigation of the Systat Parties, in its sole and absolute discretion.

 

		5.2	Upon termination of this Agreement, this Agreement shall thereafter become void and there shall
be no obligation on the part of Systat or Inpixon, except that each Party shall continue to be responsible for the obligations
set forth in this Section 5.2, Section 5.3, Section 7 and Section 9 hereof.

 

		5.3	In addition to the terms set forth in Section 5.2, above, and not by way of limitation, upon termination
or expiration of this Agreement:

 

(a)
Systat shall have the right, but not the obligation, to assume all customer, reseller and subdistributor contracts entered
into or performed by Inpixon, with Inpixon Customers or Inpixon Subdistributors, and/or Systat Customers or Systat
Subdistributors that are party to Systat Customer Contracts or Systat Subdistributor Agreements, as applicable, that were
assigned to and assumed by Inpixon hereunder and that remain in effect as of the termination of this Agreement (collectively,
the “Inpixon Contracts”), for the license, distribution and marketing of the Products during the License
Term that are in effect as of the applicable termination or expiration date (the “Inpixon Contract Assumption
Right”). Notwithstanding the foregoing, Inpixon Contracts shall not be deemed to include any customer, reseller
and/or subdistributor contracts pursuant to which Inpixon licensed, sold, or granted rights with respect to any (i) Software
Modifications, or (ii) any Inpixon or third party products that are integrated, incorporated or bundled with the Products
(collectively “Excluded Inpixon Contracts”). If Systat does not exercise the Inpixon Contract Assumption
Right, Inpixon shall retain the rights to license, use and distribute the Products, Software Source, Systat Intellectual
Property and User Documentation granted pursuant to this Agreement on a non-exclusive basis, as necessary, to provide support
to the applicable Inpixon Customers, Inpixon Subdistributors, Systat Customers and/or Systat Subdistributors (the
“Inpixon Contract Support Right”). Inpixon shall retain the Inpixon Contract Support Right with respect to
each applicable Inpixon Contract through the end of the applicable maintenance, warranty or other term set forth in such
Inpixon Contract (the “Inpixon Contract Maintenance Term”). For purposes of this section, the Inpixon
Contract Maintenance Term shall be extended to include the time during which any dispute exists between Inpixon and any
Inpixon Customers, Inpixon Subdistributors, Systat Customers and/or Systat Subdistributors concerning the Products, or
Inpixon’s obligations to provide support or warranty relief for the Products. The Parties shall work together within
thirty (30) business days from the date of termination of this Agreement to develop a transition plan. As part of this
transition plan, Systat shall notify Inpixon whether it wishes to assume Customer Maintenance and technical support. If
Systat does not notify Inpixon that it will assume Customer Maintenance and technical support, Inpixon shall provide Customer
Maintenance through the Inpixon Contract Maintenance Term and shall notify the parties to the applicable Inpixon Contracts of
termination such Inpixon Contracts in accordance with their terms and continue to provide support to applicable Inpixon
Customers, Inpixon Subdistributors, Systat Customers and/or Systat Subdistributors for a minimum of thirty (30) days from the
date of Inpixon’s delivery of a notice of termination with respect to each applicable Inpixon Contract.

 

    15

     

    

 

(b)
Subject to Section 5.3(c), upon termination or expiration of the Inpixon Contract Maintenance Terms for all of the Inpixon
Contracts, Inpixon shall return to Systat all copies of the Products, Software Source and User Documentation in the
possession of Inpixon, but excluding any Software Source Modification developed and owned by Inpixon in accordance with the
terms of this Agreement.

 

(c) Notwithstanding
anything to the contrary in Section 5.3(a) and/or 5.3(b), the Systat Parties acknowledge and agree that following any
expiration or termination of this Agreement, (i) the Systat Parties shall not have any rights with respect to the Excluded
Inpixon Contracts, and Inpixon shall have the right to continue to exercise its rights and perform its obligations pursuant
to the Excluded Inpixon Contracts, and (ii) Inpixon may require use of the Products, Software Source and User Documentation
for purposes of using and exploiting the Software Modifications and any Inpixon products integrated, incorporated, and/or
bundled with the Products and/or Software Source. Therefore, the Systat Parties will grant, and hereby grant to Inpixon,
under all of the Systat Parties’ rights therein, a nonexclusive, royalty-free, fully paid-up, perpetual, irrevocable,
worldwide license to: (1) reproduce, create derivative works of, distribute, publicly perform, publicly display, digitally
transmit, and otherwise use the Products, Software Source and User Documentation; (2) use, make, have made, sell, offer to
sell, import, and otherwise exploit any product or service based on, embodying, incorporating or derived from the Products,
Software Source and User Documentation; (3) exercise any and all other present or future rights in the Products, Software
Source and User Documentation, in each case solely as reasonably necessary or required for Inpixon to (A) exercise its rights
and perform its obligations pursuant to the Excluded Inpixon Contracts, (B) use and exploit the Software Modifications,
including, without limitation, further developing the Software Modifications or creating improvements to the Software
Modifications, and (C) use and exploit any Inpixon products integrated, incorporated, and/or bundled with the Products and/or
Software Source. In addition, Inpixon shall have a non-exclusive right and license to use the Systat Trademarks in connection
with the rights granted pursuant to this Section 5.3(c), provided, that Inpixon shall not be obligated to use the Systat
Trademarks and may use its own branding in connection with the Products, Software Modifications and User Documentation. 

 

ARTICLE 6

Representations and Warranties 

 

		6.1	Representations and Warranties of the Systat Parties. Each of the Systat Parties, represent
and warrant to Inpixon, on a joint and several basis with the understanding and intent that Inpixon will rely on such representations
and warranties upon entering into the Transaction Documents and in concluding the transactions contemplated hereby and thereby,
that:

 

(a) Organization
and Qualification. Each of the Systat Parties is organized, validly existing and in good standing under the laws of each of
the jurisdictions in which the Systat Parties are qualified to do business and has not been discontinued or dissolved under such
laws. Except as set forth on Section 6.1(a) of the Systat Disclosure Schedules, no steps or proceedings have been taken
to authorize or require such discontinuance or dissolution or the bankruptcy, insolvency, liquidation or winding up of the Systat
Parties. Each of the Systat Parties has the corporate power and capacity to own, operate or lease the properties and assets now
owned, operated or leased by it and to carry on its business as it has been and is currently conducted. Section 6.1(a) of
the Systat Disclosure Schedules sets forth each jurisdiction in which the Systat Parties are licensed or registered to carry on
business, and the Systat Parties are duly licensed or registered to carry on business and have submitted all notices or returns
of corporate information and other filings required by law to be submitted by it to any governmental authority in each jurisdiction
in which the properties owned or leased by it or the operation of its business as currently conducted makes such licensing or registration
necessary, other than where such failure would not have a Material Adverse Effect. All corporate actions taken by the Systat Parties
in connection with this Agreement and the other Transaction Documents shall be duly authorized on or before the Closing Date. The
Systat Parties have all requisite corporate power and authority to execute and deliver this Agreement and the other Transaction
Documents and to perform each of their respective obligations under the Transaction Documents. The
Transaction Documents constitute valid and binding agreements of the Systat Parties enforceable against them in accordance with
their terms.

 

    16

     

    

 

(b) Systat
Intellectual Property.

 

(i) As
of the date of this Agreement and as of the Closing Date, all required filings and fees related to the Systat Intellectual Property
have been and will be timely filed with and paid to the relevant Governmental Authorities and authorized registrars, and all required
registrations applicable to the Systat Intellectual Property (“IP Registrations”) are valid, enforceable and
in good standing. The Systat Parties have provided Inpixon with or made available to Inpixon true and complete copies of assignments,
file histories, documents, certificates, examiner’s reports, office actions, correspondence and other materials related to
the Systat Intellectual Property. The Systat Intellectual Property is used exclusively in the business of the Systat Parties which
is legally and beneficially owned by Systat Parties. The Systat Intellectual Property is not held jointly with any other Person.
The Systat Intellectual Property is valid, subsisting and enforceable and nothing has been done or omitted to be done by which
it may cease to be valid and enforceable. The Systat Parties have not created any equity, lien or other adverse interest over any
of the Systat Intellectual Property nor have agreed to grant an option right, license, sub-license, or other adverse right over
any of it to any other Person and are not obliged to do the same. None of the Systat Intellectual Property being licensed in this
Agreement is subject to any kind of restriction or right of termination.

 

(ii) Section 6.1(b)(ii) of
the Systat Disclosure Schedules lists all licenses, sublicenses, consent to use agreements, settlements, coexistence
agreements, covenants not to sue, permissions and other contracts (including any right to receive or obligation to pay
royalties or any other consideration), whether written or oral, relating to the Products and Assets to which the Systat
Parties are a party, beneficiary or otherwise bound (“IP Agreements”), but in all cases excluding (1)
confidentiality and intellectual property assignment agreements with employees, and (2) non-disclosure agreements. The Systat
Parties have provided Inpixon with or made available to Inpixon true and complete copies of all the IP Agreements required to
be disclosed in Section 6.1(b)(ii) of the Systat Disclosure Schedules, including all modifications,
amendments and supplements thereto and waivers thereunder. Each IP Agreement is valid and binding on the Systat Parties in
accordance with its terms and is in full force and effect. Neither the Systat Parties nor, to the Systat Parties’
knowledge, is any other party thereto in material breach of or material default under (or is alleged to be in material breach
of or material default under) or has provided or received any notice of material breach or material default of or any
intention to terminate or modify any IP Agreement, except such terminations or modification as may be required in accordance
with the terms of this Agreement, in each case as specifically set for on Section 6.1(b)(ii) of the Systat Disclosure
Schedules.

 

(iii)
The Systat Parties are the sole and exclusive legal and beneficial, and with respect to the IP Registrations, registered,
owner of all right, title and interest in and to the Products and Assets, and have the valid right to use the Products and
Assets in the conduct of their current operations.

 

    17

     

    

 

(iv)
The consummation of the transactions contemplated by the Transaction Documents shall not result in the loss or impairment of
or payment of any additional amounts with respect to, nor require the consent of any other Person.

 

(v) The
distribution, sale and use of the Products and Assets by the Systat Parties have not infringed, misappropriated, diluted or
otherwise violated, and do not infringe, dilute, misappropriate or otherwise violate the Intellectual Property or other
rights of any Person. The use and exploitation by Inpixon of the Products and Assets as permitted hereunder, will not
infringe, dilute, misappropriate or otherwise violate the Intellectual Property or other rights of any Person. No Person has
infringed, misappropriated, diluted or otherwise violated, or is currently infringing, misappropriating, diluting or
otherwise violating, any Systat Intellectual Property.

 

(vi)
There are no Actions (including any oppositions, expungement proceedings, interferences or re-examinations) settled, pending
or threatened (including in the form of offers to obtain a license): (1) alleging any infringement, misappropriation,
dilution or violation of the Intellectual Property of any Person by the Systat Parties; or (2) challenging the validity,
enforceability, registrability or ownership of the Systat Intellectual Property or the Systat Parties’ rights with
respect to the Systat Intellectual Property.

 

(vii)
The Systat Parties have no obligation to compensate any Person for the use of the Products or Assets.

 

(viii) Section
6.1(b)(viii) of the Systat Disclosure Schedules sets forth all Open Source Software that is included in or integrated
with (including as a programming dependency) the Products. No Open Source Software is incorporated (either directly by the
Systat Parties, or indirectly, by the incorporation of Third Party Technology that itself incorporates Open Source Software)
into or distributed with any of the Products: (1) in a manner that would grant or purport to grant to any Person any
rights to or immunities under any of the Products, or (2) under any license requiring the Systat Parties to disclose or
distribute the Source Code of any of the Products. The Systat Parties are in compliance with the terms of all licenses
applicable to the Open Source Software used by the Systat Parties in connection with the Products, including all copyright
notice and attribution requirements.

 

(c) Brokers
and Finders. The Systat Parties have not incurred or taken any action that may give rise to any liability for brokerage
fees, commissions or finder’s fees in connection with the transactions contemplated by any of the Transaction
Documents.

 

(d) Noncontravention.
Neither the execution and delivery of this Agreement and the Transaction Documents, nor the consummation of the transactions
contemplated hereby and thereby, will (i) conflict with or result in a violation or breach of, or default under, any
provision of the Articles of Incorporation, by-laws, or other documents governing the incorporation of the Systat Parties;
(ii) violate any constitution, statute, regulation, rule to which the Systat Parties are subject or, any injunction,
judgment, order, decree, ruling, charge or other restriction of any government, governmental agency, or court to which the
Systat Parties are subject, or (iii) except as set forth on Section 6.1(d) of the Systat Disclosure Schedules conflict
with, result in a breach of, constitute a default under, result in the acceleration of, create in any party the right to
accelerate, terminate, modify, or cancel, or require any notice under any agreement, contract, license, instrument, or other
arrangement to which the Systat Parties are a party or by which they are bound or to which any of the Products or other
Assets are subject (or result in the imposition of any security interest upon the Products or other Assets) and (iv) result
in the creation or imposition of any encumbrance on the Products or Assets. No consent, approval, permit, governmental order,
declaration or filing with, or notice to, any Governmental Authority is required by or with respect to the Systat Parties in
connection with the execution and delivery of this Agreement and the other Transaction Documents and the consummation of the
transactions contemplated hereby and thereby.

 

    18

     

    

 

(e) Section
6.1(e)(iv) of the Systat Disclosure Schedules sets forth the aggregate gross revenues received by the Systat Parties for
the Products by region for the calendar years 2018, 2019 and for the three month period from January 1, 2020 through March
31, 2020 are substantially accurate revenue numbers for the Products.

 

(f) Customers;
Resellers and Distributors.

 

(i)
Section 6.1(f)(i) of the Systat Disclosure Schedules sets forth: (i) the contact information including, name,
address, phone number, and email for each customer who accounted for at least $10,000 in gross revenues received by the Systat
Parties for the Products for each of the two (2) most recent calendar years (collectively, the “Material Customers”);
and (ii) the amount of consideration paid by each Material Customer to the Systat Parties during such periods. None of the
Systat Parties have received any notice, and has no reason to believe, that any of its Material Customers has ceased, or intends
to cease after the Closing Date, to use the Products or to otherwise terminate or materially reduce their purchase of the Products.
The Systat Parties have all necessary rights and consents to provide the information set forth on Section 6.1(f)(i) of the
Systat Disclosure Schedules, and providing such information to Inpixon hereunder will not constitute a breach of any agreement
between the Systat Parties and a Material Customer. 

 

(ii)
Section 6.1(f)(ii) of the Systat Disclosure Schedules sets forth: (1) each reseller or distributor of the Products
who accounted for at least $10,000 in gross revenues received by the Systat Parties for the Products for each of the two (2) most
recent calendar years (collectively, the “Material Subdistributors”); (2) the material terms and conditions
upon which the Material Subdistributors have agreed to distribute the Products including any pricing discounts or other material
obligations that the Systat Parties are required to comply with; and (3) the amount of revenue received from each Material
Subdistributor during such periods. Except for such terminations that are contemplated by this Agreement as set forth on Schedule
6.1(b)(ii) of the Systat Disclosure Schedules, none of the Systat Parties to the best of their knowledge has received any notice,
and has no reason to believe, that any of its Material Subdistributors has ceased, or intends to cease to distribute the Products
in accordance with the terms set forth on Section 6.1(f)(ii) of the Systat Disclosure Schedules or to otherwise terminate
or materially reduce its relationship with the Systat Parties. The Systat Parties have all necessary rights and consents to provide
the information set forth on Schedule 6.1(f)(ii) and providing such information to Inpixon hereunder will not constitute
a breach of any agreement between the Systat Parties and Material Subdistributor. To the extent not specified in Systat SigmaPlot
Agreements , all licenses and other rights granted by Systat to Inpixon pursuant to this Agreement with respect to the SigmaPlot
Software, including but not limited to the exclusive nature of the global rights and the right to develop the Software by Inpixon
granted herein, shall be deemed to have been granted by Cranes to Systat under Systat SigmaPlot Agreements as necessary or required
to permit the valid grant of all licenses and rights by Systat to Inpixon in accordance with the terms and conditions of this Agreement,
without any requirement of executing any amendment agreement to the Systat SigmaPlot Agreements.

 

    19

     

    

 

(g) No
Expropriation. No notice or proceeding in respect of the expropriation of any of the Products or Assets has been given or
commenced and there is not any intent or proposal to give any such notice or commence any such proceeding.

 

(h) Legal
Proceedings; Governmental Orders. Except as set forth on Section 6.1(h) of the Systat Disclosure
Schedules:

 

(i) There
are no claims, actions, enforcement actions, penalty notices, cause of actions, demands, lawsuits, arbitrations, inquiries, audits,
notice of violation, proceedings, litigations, citations, summons, subpoena, notice of assessment, notice or reassessment or investigation
of any nature, civil, criminal, administrative, investigative, regulatory or otherwise, whether at law or in equity (“Actions”),
pending or, to the knowledge of the Systat Parties threatened: (1) against or by the Systat Parties (including any affiliates
or related parties) affecting any of Products or Assets; or (2) against or by the Systat Parties or any affiliate of the Systat
Parties that concern the Products or Assets or challenges or seeks to prevent, enjoin or otherwise delay the transactions contemplated
by this Agreement and other Transaction Documents. No event has occurred or circumstances exist that may give rise to, or serve
as a reasonable basis for, any such Actions.

 

(ii) There
are no outstanding orders, writ, judgment, injunction, decree, stipulation, determination, award, decision, sanction or ruling
entered by or with any Governmental Authority and no unsatisfied judgments, penalties or awards against or affecting the Products
or Assets.

 

(i)
Compliance With Laws; Permits.

 

(i) The
Systat Parties have complied, and are now complying, with all laws applicable to the sale, distribution, and license of the Products
and Assets in all material respects.

 

(ii) All
licenses, franchises, approvals, authorizations, registrations, certificates, variances and similar rights obtained, or required
to be obtained, from Governmental Authorities (“Permits”) required for the sale, distribution, and license of
the Products and Assets have been obtained by it and are valid and in full force and effect. All fees and charges with respect
to such Permits as of the date hereof have been, and as of the Closing Date will be paid in full. Section 6.1(i)(ii) of
the Systat Disclosure Schedules lists all current Permits required for the sale and distribution of the Products, including the
names of the Permits and their respective dates of issuance and expiration. No event has occurred that, with or without notice
or lapse of time or both, would reasonably be expected to result in the revocation, suspension, lapse or limitation of any Permit
set forth in Section 6.1(i)(ii) of the Systat Disclosure Schedules.

 

(j) Full
Disclosure. No representation or warranty by the Systat Parties in this Agreement or the other Transaction Documents and
no statement contained in the Systat Disclosure Schedules to this Agreement or any certificate or other document furnished or
to be furnished to Inpixon under this Agreement contains any untrue statement of a material fact, or omits to state a
material fact necessary to make the statements contained therein, in light of the circumstances in which they are made, not
misleading.

 

(k) Product
Warranties. THE PRODUCTS AND SOFTWARE SOURCE ARE WARRANTED TO WORK IN CONFORMANCE
WITH THE USER DOCUMENTATION SUPPLIED WITH THE PRODUCTS FOR A PERIOD OF ONE-HUNDERED EIGHTY DAYS (180) FROM THE DATE OF
Delivery OF THE PRODUCTS AND SOFTWARE SOURCE TO INPIXON. The SYSTAT PARTIES’ EXCLUSIVE OBLIGATION, AND INPIXON’S
EXCLUSIVE REMEDY, SHALL BE TO CURE ANY BREACH OF THE WARRANTY SET FORTH in this Section 6.1(K) WITHIN A COMMERCIALLY
REASONABLE PERIOD OF TIME (THE “CURE PERIOD”), PROVIDED THAT INPIXON SHALL NOT BE RESPONSIBLE FOR ANY FEES
OR COSTS THAT MAY BE INCURRED IN ANY RESPECT DUE TO ANY BREACH OF WARRANTY IN ACCORDANCE WITH THIS SECTION 6.1(k) AND SYSTAT
PARTIES SHALL REIMBURSE INPIXON TO THE EXENT THAT ANY COSTS OR FEES MAY BE INCURRED.

 

    20

     

    

 

(l) No
Viruses in Products. None of the Products contain any “back door,” “time bomb,” “Trojan
horse,” “worm,” “drop dead device,” “virus”, “malware” or other
software routines or hardware components designed to permit unauthorized access or to disable or erase software, hardware or
data (“Viruses”). The Systat Parties have taken all reasonable steps necessary to prevent the introduction
of Viruses into the Products.

 

(m) Taxes.
Each of the Systat Parties shall be solely responsible for and pay all transfer, sales, use, excise, stamp duty and
other Taxes due or payable by the Systat Parties and arising or resulting from the transactions contemplated by this
Agreement, and shall, at their own expense, file all necessary returns, reports, claims or refunds, filings, declarations,
information returns, or statement relating to Taxes that are required to be filed, recorded, or deposited with any
Governmental Authority, including any attachment thereto or amendment thereof. Any stamp duty and other related charges
payable in India, if any, in relation to the Transaction Documents, shall be the sole responsibility of the Systat
Parties.

 

(n) Employee
Matters. Each of the Systat Parties is in compliance with its duties and obligations under all applicable labor and
employment-related laws, in any applicable jurisdiction, (including, but not limited to the United States, United Kingdom,
Germany, and India) and including, but not limited to, employment standards, workers’ compensation, occupational health
and safety, classification, accessibility, immigration, pay equity, and human rights to the extent applicable to the Systat
Parties within any jurisdiction in which the Systat Parties operate (including, but not limited to the United States, United
Kingdom, Germany, and India) and which the Systat Parties are required to comply with, arising from or as a result of the
consummation of the transactions contemplated by the Transaction Documents. None of the Systat Parties is subject to nor will
they or Inpixon become liable for any arrears of wages, penalties, fines, orders to pay, assessments, charges, damages or
taxes for any failure by the Systat Parties to comply with any of the foregoing arising from or as a result of the
consummation of the transactions contemplated by this Agreement. No facts exist which could reasonably be expected to give
rise to any claims with respect to applicable labor and employment-related laws in any jurisdiction in which the Systat
Parties operate or are otherwise subject to arising from or as a result of the consummation of the transactions contemplated
by this Agreement.

 

		6.2	Representations and Warranties of Inpixon.
Inpixon represents and warrants to Systat, with the understanding and intent that the Systat Parties will rely on such representations
and warranties upon entering into the Transaction Documents and in concluding the transactions contemplated hereby and thereby,
that: 

 

(a) Organization
and Qualification. Inpixon is organized, validly existing and in good standing under the laws of the state of Nevada and
in each of the jurisdictions in which Inpixon is qualified to do business. No steps or proceedings have been taken to
authorize or require such discontinuance or dissolution or the bankruptcy, insolvency, liquidation or winding up of Inpixon.
Inpixon has the corporate power and capacity to own, operate or lease the properties and assets now owned, operated or leased
by it and to carry on its business as it has been and is currently conducted.  All corporate actions taken by Inpixon in
connection with this Agreement and the other Transaction Documents shall be duly authorized on or before the Closing Date.
Inpixon has all requisite corporate power and authority to execute and deliver this Agreement and the other Transaction
Documents and to perform each of their respective obligations under the Transaction Documents. The
Transaction Documents constitute valid and binding agreements of Inpixon enforceable against it in accordance with their
terms, subject to (i) applicable bankruptcy, insolvency, reorganization, moratorium and other similar laws of general
application with respect to creditors, (ii) general principles of equity and (iii) the power of a court to deny enforcement
of remedies generally based upon public policy.

 

    21

     

    

 

(b) Non
contravention. Neither the execution and delivery of this Agreement and the Transaction Documents, nor the consummation
of the transactions contemplated hereby and thereby, will (i) conflict with or result in a violation or breach of, or default
under, any provision of the Articles of Incorporation, by-laws, or other documents governing the incorporation of Inpixon;
(ii) violate any constitution, statute, regulation, rule to which the Inpixon is subject or, any injunction, judgment, order,
decree, ruling, charge or other restriction of any government, governmental agency, or court, or (iii) conflict with, result
in a breach of, constitute a default under, result in the acceleration of, create in any party the right to accelerate,
terminate, modify, or cancel, or require any notice under any agreement, contract, license, instrument, or other arrangement
to which Inpixon is a party or that will have a Material Adverse Effect on Inpixon’s ability to carry out its
obligations under the Transaction Documents. No consent, approval, permit, governmental order, declaration or filing with, or
notice to, any Governmental Authority is required by or with respect to Inpixon in connection with the execution and delivery
of this Agreement and the other Transaction Documents and the consummation of the transactions contemplated hereby and
thereby that will not be obtained on or prior to the Closing Date.

 

ARTICLE 7

Indemnification and Covenants

 

		7.1	Indemnification by Systat Parties. The Systat Parties, which for purposes of this Section
7 shall include their officers, directors, and representatives, shall indemnify and agree to hold Inpixon (including its affiliates,
related parties, officers, directors, agents, and other representatives) (“Inpixon Parties”) harmless from any
and all losses, expenses, suits, demands, damages, liabilities, judgments, awards, costs, penalties, fines, taxes, and criminal
or civil sanctions of any nature, including reasonable attorneys’ fees and court costs, and, to the extent applicable, cost
of cover (collectively, “Losses”), arising from or related to any third party claim or action relating to: (i)
the license, distribution or use of the Products or Assets prior to the Closing Date, (ii) a claim that the Products, the Software
Source, or any other Systat Intellectual Property infringes any Intellectual Property rights of a third party, except where such
claim of infringement is based on a modification of the Products or Software Source Modifications made by Inpixon, (iii) any material
inaccuracy in or breach of any representation and warranties of the Systat Parties or Starcom contained in the Transaction Documents,
(iv) any breach or non-fulfillment of any covenant, agreement or obligations to be performed by the Systat Parties or Starcom pursuant
to the Transaction Documents, and (v) except for such modifications or amendments to the Systat SigmaPlot Agreements described
herein, any termination, amendment or other modification to the Systat Distribution Agreements or other action that results in
the termination or revocation of the rights granted to Inpixon pursuant to this Agreement for any reason other than in accordance
with Article 5 of this Agreement (each, an “Action”).

 

    22

     

    

 

		7.2	Indemnification Procedure. Inpixon
shall promptly notify Systat in writing of any Action and the reasons why indemnification is appropriate, and cooperate with the
Systat Parties at the Systat Parties’ sole cost and expense. Subject to provisions addressing the rights to enforce the rights
granted pursuant to this Agreement, at Inpixon’s sole and absolute discretion, the Systat Parties shall immediately take
control of the defense and investigation of the Action and shall employ counsel reasonably acceptable to Inpixon, to handle and
defend the Action, at the Systat Parties’ sole cost and expense. Systat shall not settle any Action in a manner that adversely
affects the rights of any of the Inpixon Parties without Inpixon’s prior written consent, which consent shall not be unreasonably
withheld, conditioned or delayed. Inpixon’s failure to perform any obligations under this paragraph shall not relieve the
Systat Parties’ of their obligation hereunder except to the extent that the Systat Parties can demonstrate that they have
been materially prejudiced as a result of the failure. Inpixon Parties may participate in and observe the proceedings at its own
cost and expense with counsel of its own choosing. In Inpixon’s sole discretion, upon written notice to Systat, Inpixon shall
have the right to offset any Losses, on a dollar for dollar basis, against the amount owed, or to be owed, by Sysorex to Systat
under any Partitioned Note (as defined in the License Note Assignment) conveyed or to be conveyed to Systat pursuant to the License
Note Assignment, so long as such Partitioned Note remains outstanding (the “Offset Right”). To the extent Inpixon
exercises the Offset Right, the amount of any Losses made subject to the Offset Right shall first reduce, on a dollar for dollar
basis, the amount owed by Sysorex to Systat under any Partitioned Note not yet conveyed to Systat pursuant to the License Note
Assignment (the “Retained Partitioned Notes”), and shall reinstate a payment obligation of Sysorex to Inpixon
under the Original Note (as defined in the License Note Assignment) in an amount equal to such Losses, which shall concurrently
reduce the amount owed by Sysorex to Systat under the applicable Retained Partitioned Note by an amount equal to such Losses (the
“Offset Procedure”). If, as a result of the Offset Procedure, the amount that would have been payable by Sysorex
to Systat pursuant to the Retained Partitioned Notes is reduced to zero, and Inpixon has Losses unrecouped by the Offset Procedure,
then Inpixon shall next apply the Offset Procedure to any outstanding Partitioned Note previously conveyed to Systat pursuant to
the License Note Assignment. Systat shall inform Inpixon in writing promptly upon satisfaction in full of Systorex’s obligations
under any Partitioned Note held by Systat.

 

		7.3	Insurance. Systat shall, at its
sole cost and expense, obtain, pay for and maintain in full force and effect commercial general liability, Intellectual Property
infringement, and indemnity insurance and other insurance in commercially reasonable and appropriate amounts as required by Inpixon
to provide coverage concerning product sales covered by the Products and contractual liability coverage for the defense and indemnification
obligations under this Agreement. Systat shall name Inpixon and its subsidiaries named in each policy as an additional insured.
Within ten (10) days of a request by Inpixon, the Systat Parties shall provide certificates of insurance or other reasonable written
evidence of all coverages described in this paragraph. Additionally, the Systat Parties shall provide Inpixon with written notice
at least sixty (60) days prior to cancelling, not renewing, or materially changing such insurance.

 

		7.4	Limitation of Liability.
IN NO EVENT SHALL EITHER PARTY BE LIABLE TO THE OTHER PARTY UNDER OR IN CONNECTION WITH THIS AGREEMENT
FOR ANY LOSS OF PROFIT OR ANY OTHER COMMERCIAL DAMAGE INCLUDING, WITHOUT LIMITATION, INCIDENTAL, CONSEQUENTIAL, SPECIAL, EXEMPLARY,
PUNITIVE OR OTHER INDIRECT DAMAGES OF ANY NATURE, FOR ANY REASON WHATSOEVER INCLUDING, WITHOUT LIMITATION, A BREACH OF THIS AGREEMENT,
or THE EXPIRATION OR ANY TERMINATION OF THIS AGREEMENT, WHETHER SUCH LIABILITY IS ASSERTED
ON THE BASIS OF CONTRACT, TORT (INCLUDING NEGLIGENCE OR STRICT LIABILITY) OR OTHERWISE, EVEN IF IT HAS BEEN WARNED OF THE POSSIBILITY
OF SUCH DAMAGES. In addition, Inpixon’s TOTAL AGGREGATE LIABILITY TO THE Systat Parties OR ANY OTHER PERSON FOR ANY AND ALL
CLAIMS AND DAMAGES ARISING FROM OR OUT OF THIS AGREEMENT (WHETHER ARISING UNDER CONTRACT, TORT, NEGLIGENCE, STRICT LIABILITY OR
OTHERWISE) SHALL IN NO EVENT EXCEED the amount of the Cash Consideration AND SYSTAT PARTIES’ TOTAL AGGREGATE LIABILITY TO
INPIXON OR ANY OTHER PERSON FOR ANY AND ALL CLAIMS AND DAMAGES ARISING FROM OR OUT OF THIS AGREEMENT (WHETHER ARISING UNDER CONTRACT,
TORT, NEGLIGENCE, STRICT LIABILITY OR OTHERWISE) SHALL IN NO EVENT EXCEED THE TOTAL CONSIDERATION.

 

    23

     

    

 

ARTICLE 8

Closing Conditions

 

		8.1	Closing Date. The closing
of the transactions pursuant to this Agreement (the “Closing”) shall take place on the Closing Date, or such
other date as the Parties shall agree to, remotely via the exchange of scanned or facsimile documents and executed signature pages.

 

		8.2	Closing Deliveries and Conditions of
the Systat Parties. The Closing shall be subject to the delivery or receipt by the Systat Parties of:

 

		(a)	in an electronic format, customer data including but not limited to lists of all prospective customers,
Material Customers and other customer names in the Territory as of the Closing Date; including the full active and inactive customer
lists and prospective customer lists for the Products held or maintained by all of the Systat Parties, which shall contain the
name, address, organization, phone number and, if available, the internal department fax number and email address of the prospects
or customers listed therein, work in progress issue tickets, communication history with customers, feature request databases and
development roadmaps (“Customer Information”);

 

		(b)	in an electronic format, any marketing materials for the Products that exist and are in their possession,
including but not limited to advertisements, web site material and brochures (hereinafter collectively called “Marketing
Material”) to be delivered to Inpixon. Systat Parties shall also provide Inpixon in electronic format, with any training
materials Systat Parties may have for the Products;

 

		(c)	a copy of the current version of the Products, the Software Source, the Systat Intellectual Property
(to the extent capable of being embodied in tangible form, and if not embodied in tangible form, described in sufficient detail
in a written document to enable Inpixon to use and exploit the applicable Systat Intellectual Property in accordance with the terms
set forth herein), the User Documentation, all documentation related to the Systat Proprietary Technology, documentation describing
in reasonable detail all current Product roadmaps, as well as applicable Product roadmaps for the immediately prior two (2) years,
and all feature requests relating to the Products, to be delivered to Inpixon;

 

		(d)	the License Note Assignment and Intercreditor Agreement, duly executed by the Parties and Sysorex;

 

		(e)	the Partitioned Note (as defined in the License Note Assignment),
duly executed by Sysorex; and

 

		(f)	evidence of approval of the Transaction Documents by the Board of Directors for each of the Systat
Parties;

 

    24

     

    

 

		(g)	evidence of payment or other satisfaction of all of the outstanding accounts receivable obligations
set forth on Schedule 8.2(f);

 

		(h)	evidence of Intellectual Property liability and indemnity insurance in such amounts and meeting
such requirements as specified by Inpixon;

 

		(i)	receipt by Systat of the Closing Consideration;

 

		(j)	the Partitioned Note duly executed by Sysorex; and

 

		(k)	the Termination & Assignment Agreement, duly executed by the Parties and Starcom
in substantially the form attached hereto as Exhibit D (“Starcom Termination Agreement”).

 

		8.3	Closing Deliveries and Conditions of Inpixon. The Closing shall be subject to the delivery
or receipt by Inpixon of:

 

		(a)	receipt of the Customer Information, Marketing Material and other material set forth in Section
8.2(c) of this Agreement;

 

		(b)	the License Note Assignment and Intercreditor Agreement, duly executed by the Parties;

 

		(c)	receipt of assignments of the Systat Distribution Agreements with respect to each of the Material
Subdistributors;

 

		(d)	receipt of assignments of the Systat Customer Contracts with respect to each of the Material Customers;

 

		(e)	delivery of the Closing Consideration;

 

		(f)	delivery of a notice to the Systat Parties that Inpixon has accepted the Products and Software
Source in accordance with Section 2.4; and

 

		(g)	the Starcom Termination Agreement, duly executed by the Parties and Starcom.

 

ARTICLE 9

Covenants 

 

		9.1	Covenant not to Use. During the License Term, except as set forth in Section 2.12 herein,
none of the Systat Parties including any direct or indirect subsidiaries, affiliates or related parties will use, modify, enhance,
distribute, market, sell, or license the Products, Systat Intellectual Property or Software Source (including for the development
of a software product or consulting services). In addition, the Systat Parties agree that any sales inquiries received by the Systat
Parties from any Person for the license or purchase of the Products during the License Term will be directed to Inpixon within
five (5) business days of any of the Systat Parties receipt of the first inquiry from such Person.

 

		9.2	Customer Revenue. Following the Closing Date, the Systat Parties will ensure that any Customer
Maintenance revenue, license fees, including new license fees or license renewal fees, or other fees or payments relating to the
Systat Customer Contracts and/or Systat Distribution Agreements that have been assigned to and assumed by Inpixon, that are received
by any of the Systat Parties after the Effective Date will be delivered to Inpixon.

 

    25

     

    

 

		9.3	Confidentiality. From and after the Effective Date, each of the Parties shall cause
its affiliates and representatives to hold in confidence any and all documents and information, whether written or oral, furnished
by or on behalf of the other Party in connection with the transactions contemplated hereby pursuant to the terms of that certain
Non-Disclosure Agreement, dated January 15, 2019, between Systat and Inpixon (the “Confidentiality Agreement”),
the terms of which are herein incorporated by reference, and which shall continue in full force and effect during the License Term.

 

		9.4	Systat SigmaPlot Agreements. Systat Parties hereby covenants that all licenses and rights
granted by Systat to Inpixon with respect to SigmaPlot Software under this Agreement, if not specifically covered in the Systat
Sigmaplot Agreements, then such licenses and rights shall be deemed to have been granted by Cranes to Systat under the SigmaPlot
Agreements without any requirement of executing any amendment agreement to the Systat SigmaPlot Agreements, and upon execution
of this Agreement, Systat SigmaPlot Agreements shall be deemed to have been mutatis mutandis amended to align with this Agreement.
Systat Parties, further covenant that in the event of any conflict between the licenses, rights granted to Systat by Cranes pursuant
to the Systat SigmaPlot Agreements and the rights granted herein, the licenses and rights granted herein shall supersede. Systat
Parties agrees that upon the request of Inpixon, the Systat Parties shall promptly take such reasonable further actions, including
execution and delivery of all appropriate instruments, letters, deeds, agreements etc., as may be necessary to give effect to the
aforesaid understanding. Systat Parties hereby also agree that they will inter se agree upon any revisions in the consideration
payable under the Systat SigmaPlot Agreements to ensure that Cranes receives adequate consideration for any additional right vested
by Cranes with Systat pursuant to this Agreement.

 

The Systat Parties confirm that
that no fees are outstanding between such parties in connection with the Systat SigmaPlot Agreements and will ensure to maintain
compliance with any applicable requirements of the Foreign Exchange Management Act or any other applicable Governmental Authority
in all material respects, and under no circumstances whatsoever, will Cranes have any kind of recourse to Inpixon for any delay
or default in payment of any fees or other dues that are required or may be required to be paid inter se between the Systat
Parties, any third party, the Foreign Exchange Management Act or any other applicable Governmental Authority in connection with
the Systat SigmaPlot Agreements.

 

		9.5	Change in Control. The Systat Parties shall provide Inpixon with no less than 15 days advance
written notice prior to entering into any agreement or consummating any transaction which shall result in the (a) consolidation,
merger or reorganization of Systat with or into another corporation or entity; (b) creation of a new majority interest in, or change
in majority ownership of Systat; or (c) sale of all or substantially all of Systat assets to any third party (“Change
in Control”). Each of the Systat Parties shall take all such action as shall be necessary to ensure that any successor
to any of the Systat Parties following a Change in Control shall be bound by and subject to the terms, conditions and obligations
of the Systat Parties set forth in the Transaction Documents.

 

		9.6	Further Assurances.  Without limiting Systat’s obligations hereunder, Systat covenants
and agrees to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable,
and to execute, or cause to be executed, all such documents as may be necessary, proper or advisable, to consummate and make effective
as promptly as practicable the transactions contemplated by this Agreement and to otherwise implement the provisions of this Agreement
fully and effectively.

 

    26

     

    

 

ARTICLE 10

General Provisions

 

		10.1	Public Announcements. Each party may provide the other party with a draft of a press release
or other public announcement for review at least three (3) business days prior to the time that such press release or other public
announcement is to be made. Failure to provide comments back to the other party within two (2) business days of receipt of the
draft release or announcement will be deemed consent to the public disclosure of such press release or other public announcement
and the content thereof, so long as the reviewing party’s name is not included in the release or announcement. Notwithstanding
anything to the contrary in this Section 10.1, no party shall issue a press release or other public announcement that includes
the name of the other party without the prior written consent of such other party (which consent may be withheld in such non-consenting
party’s sole discretion); provided, however, that Inpixon may make such public filings or disclosures as may be required
to satisfy any rules or regulations of the Securities & Exchange Commission or any securities market or exchange on which Inpixon’s
securities are listed or traded.

 

		10.2	Notices. All notices, Consents, waivers, demands and other communications required or permitted
by this Agreement shall be in writing and shall be sent by email as follows:

 

INPIXON:

 

Inpixon

2479 E. Bayshore Rd.

Palo Alto, CA

E-mail: melanie.figueroa@inpixon.com; notices@inpixon.com

Attn: Melanie Figueroa, General Counsel

 

With concurrent copies, which shall not constitute
notice, to:

 

Greenberg Traurig,
LLP

 

Attention:
Kevin Friedmann, Esq.

Email Address: friedmannk@gtlaw.com

 

Systat Parties:

 

****

 

With a copy, which
shall not constitute notice, to:

 

****

 

All such
notices, Consents, waivers, demands and other communications shall be deemed to have been duly given on the business day sent (or
next business day if not sent on a business day or not sent during normal business hours of the recipient) by email to the designated
email address set forth above (or to such other email address as a party may designate by written notice to the other parties),
provided the sender produces a record of transmission if requested by the addressee.

 

		10.3	Enforcement of Agreement. Each Party hereto acknowledges and agrees that the other Party
would be irreparably damaged if any of the provisions of this Agreement are not performed in accordance with their specific terms
and that any breach of this Agreement by either Party could not be adequately compensated in all cases by monetary damages alone.
Accordingly, in addition to any other right or remedy to which each Party may be entitled, at law or in equity, it shall be entitled
to enforce any provision of this Agreement by a decree of specific performance and to temporary, preliminary and permanent injunctive
relief to prevent breaches or threatened breaches of any of the provisions of this Agreement, without posting any bond or other
undertaking.

 

    27

     

    

 

		10.4	Waiver; Extension; Remedies Cumulative. The rights and remedies of the Parties to this Agreement
are cumulative and not alternative. Neither any failure nor any delay by any Party in exercising any right, power or privilege
under this Agreement or any of the documents referred to in this Agreement will operate as a waiver of such right, power or privilege,
and no single or partial exercise of any such right, power or privilege will preclude any other or further exercise of such right,
power or privilege or the exercise of any other right, power or privilege. At any time prior to the completion of the Closing,
the Parties hereto may, to the extent legally allowed, (a) extend the time for the performance of any of the obligations or other
acts of the other Parties hereto, (b) waive any inaccuracies in the representations and warranties contained herein or in any document
delivered pursuant hereto, and (c) waive compliance with any of the agreements or conditions contained herein. Any agreement on
the part of a Party hereto to any such extension or waiver shall be valid only if set forth in a written instrument signed on behalf
of the Party to be charged with such waiver or for whose benefit the covenant or condition exists, but such extension or waiver
or failure or delay to insist on strict compliance with an obligation, covenant, agreement or condition shall not operate as a
waiver of, or estoppel with respect to, any subsequent or other failure.

  

		10.5	Entire Agreement. This Agreement, together with its Exhibits and Schedules, the Transaction
Documents, and the Confidentiality Agreement, constitute the entire agreement between the Parties with respect to the subject matters
hereof and thereof and cancels and supersedes any prior understandings, agreements, negotiations and discussions between the Parties
with respect thereto.

 

		10.6	Amendment. No amendment or waiver of any provision of this Agreement shall be valid unless
the same shall be in writing and signed by the Parties.

 

		10.7	Assignments, Successors and No Third-Party Rights. During the License Term, except as permitted
in accordance with the terms of the Transaction Documents, no Party may assign any of its rights or delegate any of its obligations
under this Agreement without the prior written consent of the other, except to a designated direct or indirect subsidiary, affiliate
or related party, or as otherwise provided in this Agreement. Subject to the preceding sentence, this Agreement will apply to,
be binding in all respects upon and inure to the benefit of the successors and permitted assigns of the Parties. Nothing expressed
or referred to in this Agreement will be construed to give any Person other than the Parties to this Agreement, or any indemnified
party pursuant to ARTICLE 7, any legal or equitable right, remedy or claim under or with respect to this Agreement or any provision
of this Agreement, except such rights as shall inure to a successor or permitted assignee pursuant to this Section 10.7.

 

		10.8	Severability. If any provision of this Agreement is held invalid or unenforceable by any
court of competent jurisdiction, the other provisions of this Agreement will remain in full force and effect. Any provision of
this Agreement held invalid or unenforceable only in part or degree will remain in full force and effect to the extent not held
invalid or unenforceable.

 

		10.9	Construction. The headings of Articles and Sections in this Agreement are provided for convenience
only and will not affect its construction or interpretation. All references to “Articles,” “Sections” refer
to the corresponding Articles and Sections of this Agreement and the Exhibits and Schedules. This Agreement was negotiated by the
Parties with the benefit of legal representation, and any rule of construction or interpretation otherwise requiring this Agreement
to be construed or interpreted against any Party shall not apply to any construction or interpretation hereof. As used herein,
the term “including” shall be deemed to mean “including, without limitation”, if not so specified.

 

    28

     

    

 

		10.10	Time of Essence. With regard to all dates and time periods set forth or referred to in this
Agreement, time is of the essence.

 

		10.11	Governing Law; Jurisdiction. This Agreement will be governed by and construed under the
laws of the State of California without regard to conflicts-of-laws principles that would require the application of any other
Law. Any proceeding arising out of or relating to this Agreement or any other Transaction Document shall be brought in the state
or federal courts located in San Francisco or Santa Clara County, California, and each Party irrevocably submits to the exclusive
jurisdiction of each such court in any such proceeding, waives any objection it may now or hereafter have to venue or to convenience
of forum, agrees that all claims in respect of the proceeding shall be heard and determined only in any such court and agrees not
to bring any proceeding arising out of or relating to this Agreement or any other Transaction Document in any other court.

 

		10.12	Execution of Agreement. This Agreement may be executed
in one (1) or more counterparts, each of which will be deemed to be an original copy of this Agreement and all of which, when
taken together, will be deemed to constitute one and the same agreement. The exchange of copies of this Agreement and of signature
pages by facsimile or email transmission shall constitute effective execution and delivery of this Agreement as to the Parties
and may be used in lieu of the original Agreement for all purposes. Signatures of the Parties transmitted by facsimile or email
shall be deemed to be their original signatures for all purposes.

 

		10.13	No Representative. Except as set forth in Section 2.15 of this Agreement, nothing contained
in this Agreement, nor any action taken by any Party to this Agreement, shall be deemed to constitute the other Party (or any of
the other party’s employees, agents, or representatives) an employee, agent, or legal representative of the Party, nor to
create any, joint venture, association, or syndicate among or between the Parties, nor to confer on either party any express or
implied right, power or authority to enter into any agreement or commitment on behalf or (nor to impose any obligation upon) the
other Party.

 

		10.14	Bankruptcy. All rights and licenses granted by the Systat Parties under this Agreement are
and will be deemed to be rights and licenses to “intellectual property” as such term is used in, and interpreted under,
Section 365(n) of the United States Bankruptcy Code (the “Bankruptcy Code”) (11 U.S.C. § 365(n)). Inpixon
has all rights, elections, and protections under the Bankruptcy Code and all other bankruptcy, insolvency, and similar laws with
respect to the Agreement, and the subject matter hereof. Without limiting the generality of the foregoing, the Systat Parties acknowledge
and agrees that, if the Systat Parties or their estate shall become subject to any bankruptcy or similar proceeding, subject to
Inpixon’s rights of election under Section 365(n), all rights, licenses, and privileges granted to Inpixon under this Agreement
will continue subject to the respective terms and conditions hereof, and will not be affected. If the Systat Parties or any successor
rejects this Agreement, as provided in the Bankruptcy Code, Inpixon shall be entitled to a complete duplicate of, or complete access
to, as appropriate, all such intellectual property and embodiments of intellectual property, which, if not already in Inpixon’s
possession, shall be promptly delivered to Inpixon or its designee, unless the Systat Parties elects to and does in fact continue
to perform all of its obligations under this Agreement.

 

		10.15	Expenses. Except as otherwise expressly provided herein, all costs and expenses, including
fees, disbursements and charges of counsel, financial advisors and accountants, incurred in connection with this Agreement and
the transactions contemplated hereby shall be paid by the Party incurring such costs and expenses, whether or not the Closing Date
shall have occurred.

 

[SIGNATURE PAGE FOLLOWS]

 

    29

     

    

 

IN WITNESS HEREOF,
the Parties represent and warrant that this Agreement is executed by duly authorized representatives of each Party on the date
set forth below.

 

	INPIXON	 	CRANES SOFTWARE INTERNATIONAL LTD.
	 	 	 	 
	By:	/s/ Nadir Ali	 	By:	/s/ Asif Khader
	Name:	Nadir Ali	 	Name:	/s/ Asif Khader
	Title:	CEO	 	Title:	Managing Director
	Date:	June 19, 2020	 	Date:	June 19, 2020
	 	 	 	 	 
	 	 	 	SYSTAT SOFTWARE, INC.
	 	 	 	 	 
	 	 	 	By:	/s/ Tanveer A. Khader
	 	 	 	Name:	Tanveer A. Khader
	 	 	 	Title:	Vice President
	 	 	 	Date:	June 19, 2020

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00310-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00310-of-00352.parquet"}]]